LBSR Liberty Star Uranium and Metals Corporation (QB)

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

 

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended October 31, 2024

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from __________ to __________

 

Commission file number 000-50071

 

LIBERTY STAR URANIUM & METALS CORP.

(Exact name of registrant as specified in its charter)

 

Nevada		90-0175540
(State or other jurisdiction of incorporation or organization)		(IRS Employer Identification No.)

 

2 East Congress Street Ste. 900, Tucson, Arizona		85701
(Address of principal executive offices)		(Zip code)

 

520-425-1433

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act: None.

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large, accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
		Emerging growth company	☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

 

The number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 51,945,913 common shares as of December 16, 2024.

 

 

 

TABLE OF CONTENTS

 

			Page
	PART I
Item 1.	Financial Statements		4
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		17
Item 3.	Quantitative and Qualitative Disclosures About Market Risk		23
Item 4.	Controls and Procedures		23
	PART II
Item 1.	Legal Proceedings		24
Item 1A.	Risk Factors		24
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds		25
Item 3.	Defaults Upon Senior Securities		25
Item 4.	Mine Safety Disclosures		25
Item 5.	Other Information		25
Item 6.	Exhibits		26
	Signatures		27

 

 

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

 

This quarterly report contains forward-looking statements. These statements relate to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may”, “should”, “expects”, “plans”, “anticipates”, “believes”, “estimates”, “predicts”, “potential” or “continue” or the negative of these terms or other comparable terminology.

 

These statements are only predictions and involve known and unknown risks, uncertainties and other factors that may cause our or our industry’s actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. While these forward-looking statements, and any assumptions upon which they are based, are made in good faith and reflect our current judgment regarding the direction of our business, actual results will almost always vary, sometimes materially, from any estimates, predictions, projections, assumptions or other future performance suggested herein. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. Except as required by applicable law, including the securities laws of the United States we do not intend to update any of the forward-looking statements to conform these statements to actual results.

 

Factors that might cause or contribute to such differences include, but are not limited to, those discussed elsewhere in this Report, including under “Risk Factors”, and in other reports the Company files with the Securities and Exchange Commission (“SEC” or the “Commission”), including the Company’s Annual Report on Form 10-K for the year ended January 31, 2024 (under the heading “Risk Factors” and in other parts of that report), which factors include:

 

	●	Because of the nature of the exploration of natural resource properties, there is substantial risk that this business will fail.
	●	If we cannot compete successfully for financing and for qualified managerial and technical employees, our exploration program may suffer.
	●	Exploration and exploitation activities are subject to comprehensive regulation which may cause substantial delays or require capital outlays in excess of those anticipated, causing an adverse effect on our company.
	●	There are no known reserves of minerals on our mineral claims, and we cannot guarantee that we will find any commercial quantities of minerals.
	●	Because the probability of an individual prospect ever having reserves is extremely remote, any funds spent on exploration may be lost.
	●	We have a limited operating history and as a result there is no assurance we can operate on a profitable basis.
	●	If we do not obtain additional financing, our business will fail, and our investors could lose their investment.
	●	Because there is no assurance that we will generate revenues, we face a high risk of business failure.
	●	The existence of our mining claims depends on our ability to fund exploratory activity or to pay fees.

 

Our consolidated financial statements are stated in United States Dollars (“US$”) and are prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial statements. The following discussion should be read in conjunction with our consolidated financial statements and the related notes that appear elsewhere in this quarterly report. As used in this quarterly report, the terms “we”, “us”, “the Company”, and “Liberty Star” mean Liberty Star Uranium & Metals Corp. and our subsidiaries, Hay Mountain Holdings, LLC, Earp Ridge Mines LLC and Red Rock Mines LLC, unless otherwise indicated. All dollar amounts refer to U.S. dollars unless otherwise indicated.

 

 

PART I – FINANCIAL INFORMATION

 

Item 1. Financial Statements.

 

Liberty Star Uranium & Metals Corp.

Consolidated Balance Sheets

(Unaudited)

 

		October 31,				January 31,
		2024				2024
Assets
Current assets:
Cash and cash equivalents		$	27,158			$	72,099
Prepaid expenses and other current assets			21,188				14,356
Total current assets			48,346				86,455
Noncurrent assets:
Property and equipment, net			12,792				17,644
Deferred financing costs			20,000				-
Total noncurrent assets			32,792				17,644
Total assets		$	81,138			$	104,099
Liabilities and Stockholders’ Deficit
Current:
Accounts payable and accrued liabilities		$	238,151			$	165,212
Accrued expenses, related party			8,117				-
Advances, related party			185,000				-
Note payable			8,522				-
Notes payable to related party			736,598				326,828
Notes payable			736,598				326,828
Convertible promissory note, net of unamortized debt discount of $39,917 and $0			200,983				95,000
Derivative liability			637,477				2,547,458
Total current liabilities			2,014,848				3,134,498
Long-term:
Long-term debt - SBA, net of current portion			32,400				32,400
Total long-term liabilities			32,400				32,400
Total liabilities			2,047,248				3,166,898
Commitments and Contingencies			-				-
Stockholders’ deficit:
Class A common stock - $.00001 par value; 500,000 authorized; 500,000 shares issued and outstanding			5				5
Common stock - $.00001 par value; 149,500,000 authorized; 51,156,228 and 49,813,861 shares issued and outstanding, respectively			512				498
Additional paid-in capital			57,230,440				58,538,033
Subscription receivable			(101,100	)			(117,850	)
Accumulated deficit			(59,095,967	)			(61,483,485	)
Total stockholders’ deficit			(1,966,110	)			(3,062,799	)
Total liabilities and stockholders’ deficit		$	81,138			$	104,099

 

The accompanying notes are an integral part of the unaudited consolidated financial statements.

 

 

Liberty Star Uranium & Metals Corp.

Consolidated Statements of Operations

(Unaudited)

 

		2024				2023				2024				2023
		For the three months ended								For the nine months ended
		October 31,								October 31,
		2024				2023				2024				2023
Revenues		$	-			$	-			$	-			$	-
Expenses:
Geological and geophysical costs			42,300				112,104				409,987				125,792
Salaries and benefits			56,806				55,737				176,805				152,419
Professional services			46,691				33,904				189,092				121,437
General and administrative			133,693				49,422				441,751				127,851
Net operating expenses			279,490				251,167				1,217,635				527,499
Loss from operations			(279,490	)			(251,167	)			(1,217,635	)			(527,499	)
Other income (expense):
Interest expense			(83,932	)			(88,680	)			(180,785	)			(209,984	)
Other income			956				1,126				2,882				2,365
Gain on change in fair value of derivative liability			1,289,458				86,112				3,783,056				160,551
Total other income (expense)			1,206,482				(1,442	)			3,605,153				(47,068	)
Net income (loss)		$	926,992			$	(252,609	)		$	2,387,518			$	(574,567	)
Net income (loss) per share of common stock – basic		$	0.02			$	(0.01	)		$	0.05			$	(0.02	)
Net income (loss) per share of common stock - diluted		$	0.02			$	(0.01	)		$	0.04			$	(0.02	)
Weighted average shares outstanding - basic			50,794,090				32,289,211				50,193,594				24,676,301
Weighted average shares outstanding - diluted			61,601,303				32,289,211				62,349,267				24,676,301

 

The accompanying notes are an integral part of the unaudited consolidated financial statements.

 

 

Liberty Star Uranium & Metals Corp.

Consolidated Statements of Changes in Stockholders’ Deficit

For the nine months ended October 31, 2024 and 2023

(Unaudited)

 

		Shares				Amount				Shares				Amount				Receivable				Capital				Deficit				Deficit
		Class A Common stock								Common stock								Subscription				Additional paid-in				Accumulated				Total Stockholders’
		Shares				Amount				Shares				Amount				Receivable				Capital				Deficit				Deficit
Balance, January 31, 2024			500,000			$	5				49,813,861			$	498			$	(117,850	)		$	58,538,033			$	(61,483,485	)		$	(3,062,799	)
Cashless exercise of options			-				-				70,002				1				-				(1	)			-				-
Stock based compensation			-				-				-				-				-				77,626				-				77,626
Settlement of subscription receivable			-				-				-				-				16,750				-				-				16,750
Net income for the three months ended April 30, 2024			-				-				-				-				-				-				311,381				311,381
Balance, April 30, 2024			500,000				5				49,883,863				499				(101,100	)			58,615,658				(61,172,104	)			(2,657,042	)
Shares issued for conversion of notes			-				-				185,381				2				-				34,998				-				35,000
Stock based compensation			-				-				-				-				-				173,569				-				173,569
Resolution of derivative liabilities due to debt conversions			-				-				-				-				-				17,739				-				17,739
Reclass of APIC to derivative liabilities for tainted warrants			-				-				-				-				-				(3,331,913	)			-				(3,331,913	)
Net income for the three months ended July 31, 2024			-				-				-				-				-				-				1,149,145				1,149,145
Balance, July 31, 2024			500,000				5				50,069,244				501				(101,100	)			55,510,051				(60,022,959	)			(4,613,502	)
Shares issued for cash, net			-				-				79,976				1				-				6,413				-				6,414
Shares issued for deferred financing costs			-				-				100,000				1				-				19,999				-				20,000
Shares issued for conversion of notes			-				-				682,008				7				-				79,393				-				79,400
Stock based compensation			-				-				225,000				2				-				106,133				-				106,135
Resolution of derivative liabilities due to debt conversions			-				-				-				-				-				34,737				-				34,737
Reclass of APIC to derivative liabilities for tainted warrants			-				-				-				-				-				1,473,714				-				1,473,714
Net income for the three months ended October 31, 2024			-				-				-				-				-				-				926,992				926,992
Balance, October 31, 2024			500,000			$	5				51,156,228			$	512			$	(101,100	)		$	57,230,440			$	(59,095,967	)		$	(1,966,110	)

 

Balance, January 31, 2023			102,000			$	1				18,671,159			$	186			$	(117,468	)		$	56,941,222			$	(57,403,227	)		$	(579,286	)
Receipt of subscription receivable			-				-				-				-				16,368				-				-				16,368
Cashless exercise of options			-				-				250,000				3				(16,750	)			16,747				-				-
Shares issued for conversion of notes			-				-				1,251,270				13				-				70,930				-				70,943
Stock based compensation			-				-				-				-				-				19,265				-				19,265
Resolution of derivative liabilities due to debt conversions and untainted warrants			-				-				-				-				-				43,931				-				43,931
Net loss for the three months ended April 30, 2023			-				-				-				-				-				-				(118,579	)			(118,579	)
Balance, April 30, 2023			102,000				1				20,172,429				202				(117,850	)			57,092,095				(57,521,806	)			(547,358	)
Issuance of common stock and warrants in private placement			-				-				3,542,778				35				-				159,965				-				160,000
Shares issued for conversion of notes			-				-				1,690,073				17				-				61,078				-				61,095
Stock based compensation			-				-				978,300				10				-				24,354				-				24,364
Resolution of derivative liabilities due to debt conversions and untainted warrants			-				-				-				-				-				125,520				-				125,520
Net loss for the three months ended July 31, 2023			-				-				-				-				-				-				(203,379	)			(203,379	)
Balance, July 31, 2023			102,000				1				26,383,580				264				(117,850	)			57,463,012				(57,725,185	)			(379,758	)
Balance			102,000				1				26,383,580				264				(117,850	)			57,463,012				(57,725,185	)			(379,758	)
Issuance of common stock and warrants in private placement			398,000				4				20,454,707				205				-				851,201				-				851,410
Shares issued for conversion of notes			-				-				2,725,574				27				-				101,215				-				101,242
Shares exchanged			(250,000	)			(2	)			250,000				2				-				-				-				-
Stock based compensation			-				-				-				-				-				19,614				-				19,614
Resolution of derivative liabilities due to debt conversions and untainted warrants			-				-				-				-				-				(11,241	)			-				(11,241	)
Net loss for the three months ended October 31, 2023			-				-				-				-				-				-				(252,609	)			(252,609	)
Net income ( loss)			-				-				-				-				-				-				(252,609	)			(252,609	)
Balance, October 31, 2023			250,000			$	3				49,813,861			$	498			$	(117,850	)		$	58,423,801			$	(57,977,794	)		$	328,658
Balance			250,000			$	3				49,813,861			$	498			$	(117,850	)		$	58,423,801			$	(57,977,794	)		$	328,658

 

The accompanying notes are an integral part of the unaudited consolidated financial statements.

 

 

Liberty Star Uranium & Metals Corp.

Consolidated Statements of Cash Flows

(Unaudited)

 

		2024				2023
		For the nine months ended
		October 31,
		2024				2023
Cash flows from operating activities:
Net income (loss)		$	2,387,518			$	(574,567	)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation			4,852				4,534
Stock based compensation			357,330				63,243
Amortization of debt discounts			112,835				197,477
Gain on change in fair value of derivative liabilities			(3,783,056	)			(160,551	)
Changes in assets and liabilities:
Prepaid expenses			17,438				8,544
Accounts payable and accrued expenses			77,339				37,017
Accrued expenses to related party			8,117				-
Cash flows used in operating activities:			(817,627	)			(424,303	)
Cash flows from financing activities:
Proceeds from advances, related party			210,000				1,363
Repayments of advances, related party			(25,000	)			-
Proceeds from notes payable, related party			467,000				35,000
Repayment on notes payable, related party			(40,000	)			-
Repayments on notes payable			(16,228	)			(19,058	)
Proceeds from convertible promissory notes			286,000				80,000
Repayments on convertible promissory notes			(115,500	)			-
Proceeds from the issuance of common stock for cash, net			6,414				-
Proceeds from the issuance of common stock and warrants in a private placement			-				999,751
Receipt of subscription receivable			-				16,368
Net cash provided by financing activities			772,686				1,113,424
Increase (decrease) in cash and cash equivalents			(44,941	)			689,121
Cash and cash equivalents, beginning of period			72,099				32,616
Cash and cash equivalents, end of period		$	27,158			$	721,737
Supplemental disclosure of cash flow information:
Income tax paid		$	-			$	-
Interest paid		$	948			$	-
Supplemental disclosure of non-cash items:
Resolution of derivative liabilities due to debt conversions and untainted warrants		$	52,476			$	156,309
Reclass of APIC to derivative liabilities for tainted warrants		$	1,858,199			$	1,901
Debt discounts due to derivative liabilities		$	67,352			$	146,368
Shares issued for conversion of debt and interest		$	114,400			$	233,280
Expenses paid by related party on behalf of the Company		$	-			$	21,828
Prepaid insurance financed with note payable		$	24,750			$	24,850
Cashless exercise of warrants		$	-			$	16,750
Settlement of subscription and interest receivable		$	17,230			$	-
Non-cash equipment addition		$	-			$	1,908
Non-cash payment on note payable, related party		$	-			$	9,751
Shares issued for deferred financing costs		$	20,000			$	-

 

The accompanying notes are an integral part of the unaudited consolidated financial statements.

 

 

LIBERTY STAR URANIUM & METALS CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

NOTE 1 – Basis of Presentation

 

The consolidated financial statements included herein have been prepared by Liberty Star Uranium & Metals Corp. (the “Company”, “we”, “our”) without audit, pursuant to the rules and regulations of the United States Securities and Exchange Commission (“SEC”) and should be read in conjunction with our annual report on Form 10-K for the year ended January 31, 2024 as filed with the SEC on May 15, 2024. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) have been omitted, as permitted by the SEC, although we believe the disclosures which are made are adequate to make the information presented not misleading. The consolidated financial statements reflect, in the opinion of management, all normal recurring adjustments necessary to present fairly our financial position at October 31, 2024, and the results of our operations and cash flows for the periods presented.

 

Interim results are subject to significant seasonal variations and the results of operations for the three and nine months ended October 31, 2024, are not necessarily indicative of the results to be expected for the full year.

 

NOTE 2 – Going Concern

 

The Company has a history of and expects to continue to report stockholders’ deficit, negative cash flows from operations and loss from operations. Additional funds are required for further exploratory activity and to maintain its claims prior to attaining a revenue generating status. There are no assurances that a commercially viable mineral deposit exists on any of our properties. In addition, the Company may not find sufficient ore reserves to be commercially mined. As such, there is substantial doubt about the Company’s ability to continue as a going concern.

 

Management is working to secure additional funds through the exercise of stock warrants already outstanding, equity financing, debt financing or joint venture agreements. The consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties.

 

NOTE 3 – Summary of Significant Accounting Policies

 

Fair Value

 

Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) ASC 820 Fair Value Measurements and Disclosures (“ASC 820”), defines fair value, establishes a framework for measuring fair value and enhances disclosures about fair value measurements. It defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value:

 

Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities.

 

Level 2: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities that are not active; and model-driven valuations whose inputs are observable or whose significant value drivers are observable. Valuations may be obtained from, or corroborated by, third-party pricing services.

 

Level 3: Unobservable inputs to measure fair value of assets and liabilities for which there is little, if any market activity at the measurement date, using reasonable inputs and assumptions based upon the best information at the time, to the extent that inputs are available without undue cost and effort.

 

8

 

 Schedule of Fair Value of Financial Instruments

							Fair value measurements at reporting date using:
Description			Fair Value				Quoted prices in active markets for identical liabilities (Level 1)				Significant other observable inputs (Level 2)				Significant unobservable inputs (Level 3)
Warrant and convertible note derivative liabilities at October 31, 2024		$	637,477				–				–			$	637,477
Warrant and convertible note derivative liabilities at January 31, 2024		$	2,547,458				–				–			$	2,547,458

 

Our financial instruments consist of cash and cash equivalents, prepaid expenses, accounts payable, accrued liabilities, notes payable, convertible notes payable, and derivative liabilities. It is management’s opinion that we are not exposed to significant interest, currency or credit risks arising from these financial instruments. With the exception of the derivative liabilities, the fair value of these financial instruments approximates their carrying values based on their short maturities or for long-term debt based on borrowing rates currently available to us for loans with similar terms and maturities. Gains and losses recognized on changes in estimated fair value of the derivative liabilities are reported in other income (expense) as gain (loss) on change in fair value of derivative liabilities.

 

Net income (loss) per share

 

Basic net income (loss) per common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding during the period. Potential common stock equivalents are determined using the treasury stock method. For diluted net income (loss) per share purposes, the Company excludes stock options and other stock-based awards, including shares issued as a result of option exercises that are subject to repurchase by the Company, whose effect would be anti-dilutive from the calculation.

 

During the three and nine months ended October 31, 2024, the impact of 1,525,386 and 1,743,667 of stock options and 9,281,827 and 10,412,006 of warrants and 0 shares issuable from convertible notes, respectively, were considered for their dilutive effects. During the three and nine months ended October 31, 2023, the impact of 0 of stock options, 2,099,941 and 3,450,319 of warrants, respectively, were excluded from the calculation as their impact would be anti-dilutive.

 

A reconciliation of the weighted average shares outstanding used in basic and diluted earnings per share computation is as follows:

 Schedule of Reconciliation of Weighted Average Shares Outstanding

		2024				2023				2024				2023
		For the Three Months Ended								For the Nine Months Ended
		October 31,								October 31,
		2024				2023				2024				2023
Basic income (loss) per common share
Net income (loss) available to common shareholders		$	926,992			$	(252,609	)		$	2,387,518			$	(574,567	)
Derivative (gain) loss associated with convertible debt			(11,432	)			-				(14,876	)			-
Interest expense associated with convertible debt			(5,142	)			-				(16,415	)			-
Net income (loss) for dilutive calculation		$	910,418			$	(252,609	)		$	2,356,227			$	(574,567	)
Weighted average common shares outstanding			50,794,090				32,289,211				50,193,594				24,676,301
Dilutive effect of convertible debt			-				-				-				-
Dilutive effect of common stock warrants			9,281,827				-				10,412,006				-
Dilutive effect of common stock options			1,525,386				-				1,743,667				-
Weighted average shares outstanding for diluted net income (loss) per share			61,601,303				32,289,211				62,349,267				24,676,301

 

 

9

 

 

NOTE 4 – Related Party Transactions

 

Our CEO, Brett Gross, was elected as President and Chief Executive Officer on December 7, 2018. On September 29, 2023, Mr. Gross resigned from his position as President and Chief Executive Officer of the Company. Patricia Madaris, VP Finance and Chief Financial Officer will serve as the Interim Chief Executive Officer.

 

Accrued Expenses

 

As of October 31, 2024, and January 31, 2024, we had a balance of accrued unpaid vacation days of $8,117 and $0, respectively, to Patricia Madaris, VP Finance & CFO.

 

Advances

 

During the nine months ended October 31, 2024, the Company received advances of $210,000 from Pete O’Heeron, Chairman of the Board, and repaid $25,000 of advances. The advances are unsecured, non-interest bearing and is payable on demand. As of October 31, 2024, the advances related party balance was $185,000.

 

Note payable

 

On January 31, 2023, the Company entered into a promissory note with Brett Gross for $50,000 and received cash proceeds. During the year ended January 31, 2024, the Company signed an addendum to the January 31, 2023 promissory note to increase the promissory note with Mr. Gross to $86,579. The note bears interest at 10% and matures on January 31, 2024. On February 12, 2024, the Company signed an addendum to the January 31, 2023 promissory note to net the $16,750 recourse loan with Mr. Gross and accrued interest of $480 with the promissory note. During the nine months ended October 31, 2024, the Company repaid Mr. Gross $40,000. As of October 31, 2024 and January 31, 2024, the note payable related party balance was $19,598 and $76,828, respectively.

 

On January 25, 2024, the Company entered into a promissory note with Pete O’Heeron, Chairman of the Board, for $250,000 and received cash proceeds. The note bears interest at 10% and matures on January 25, 2025.

 

On February 13, 2024, the Company entered into a promissory note with Pete O’Heeron, Chairman of the Board, in the aggregate principal amount of $210,000. The note bears interest at 10% matures on February 13, 2025.

 

On April 3, 2024, the Company entered into a promissory note with Pete O’Heeron, Chairman of the Board, in the aggregate principal amount of $75,000. The note bears interest at 10% matures on April 3, 2025.

 

On May 1, 2024, the Company entered into a promissory note with Pete O’Heeron, Chairman of the Board, in the aggregate principal amount of $45,000. The note bears interest at 10% matures on May 1, 2025.

 

On May 20, 2024, the Company entered into a promissory note with Pete O’Heeron, Chairman of the Board, in the aggregate principal amount of $67,000. The note bears interest at 10% matures on May 20, 2025.

 

On July 5, 2024, the Company entered into a promissory note with Pete O’Heeron, Chairman of the Board, in the aggregate principal amount of $70,000. The note bears interest at 10% matures on July 5, 2025.

 

As of October 31, 2024, and January 31, 2024, the note payable related party balance was $736,598 and $326,828, respectively.

 

Other

 

On February 21, 2024, the Company received a notice to exercise 75,000 options to purchase shares of common stock on a cashless basis resulting in the issuance of a net of 70,002 shares of common stock.

 

On June 28, 2024, the Company granted 337,501 options to an officer and a member of the board of directors. The options expire ten years following issuance and have an exercise price of $0.226. The options vest upon issuance and have a total fair value of $76,275. The Company valued the options using the Black-Scholes model with the following key assumptions: fair value stock price, $0.226, Exercise price, $0.226, Term 10 years, Volatility 178%, and Discount rate 4.36% and a dividend yield of 0%.

 

10

 

 

NOTE 5 – Stockholders’ deficit

 

Common Stock

 

Our common shares are all of the same class, are voting and entitle stockholders to receive dividends to the extent declared by the Board of Directors. Upon liquidation or wind-up, stockholders are entitled to participate equally with respect to any distribution of net assets.

 

On July 3, 2024, the Board of Directors amended the articles of incorporation to increase the Company’s common stock by 75,000,000 shares.

 

Common Stock for Services

 

On May 26, 2023, the Company entered into a twelve-month stock compensation and subscription agreement with an investor relations firm that includes the issuance of 978,300 shares of restricted common stock. Upon signing the agreement, the Company issued 978,300 shares of restricted common stock and will recognize the expense over the twelve-month service period. The shares of restricted common stock will be subject to a six-month hold period from the date of issuance. During the nine months ended October 31, 2024, the Company recognized $12,229 of expense related to this agreement.

 

On August 5, 2024, the Company entered into a twelve-month stock compensation and subscription agreement with an investor relations firm that includes the issuance of 225,000 shares of restricted common stock with a fair value of $45,000. During the nine months ended October 31, 2024, the Company recognized $45,000 of expense related to this agreement.

 

Equity Financing

 

On September 25, 2024, the Company entered into an investment agreement (the “Investment Agreement”) with GHS Investments, LLC (the “Investor”), whereby the Investor has agreed to invest up to $10,000,000 to purchase shares of our common stock over a 24-month-term that commenced on September 25, 2024. Subject to the terms and conditions of the Investment Agreement and Registration Agreement, we may, in our sole discretion, deliver a put notice to the Investor which states the dollar amount which we intend to sell to the Investor on a certain date. The amount that we shall be entitled to sell to Investor shall be equal to two hundred percent (200%) of the average daily volume (U.S. market only) of the common stock for the ten (10) trading days prior to the applicable notice date so long as such amount does not exceed a calculated dollar amount per every 10 days of $500,000. The minimum amount shall be equal to $10,000. On October 24, 2024, the Investor purchased 79,976 restricted shares of the Company’s common stock for net proceeds of $6,414 ($0.08 per share), after deducting the legal fees and clearing expenses. As consideration for entering into the purchase agreement, the Company issued 100,000 shares of common stock to the Investor as a commitment fee. The shares were valued at approximately $20,000 and were recorded as deferred offering costs on the balance sheet. The deferred charges will be charged against paid-in capital upon future proceeds from the sale of common stock under this agreement. During the nine months ended October 31, 2024, $1,000 of deferred offering cost was charged against paid-in capital. As of October 31, 2024, unamortized deferred offering costs totaled $20,000.

 

Shares Issued for Conversion of Notes

 

During the nine months ended October 31, 2024, the Company issued a total of 867,389 shares of our common stock for conversions of $110,000 in principal and $4,000 of interest on convertible notes payable at an exercise price ranging from $0.0961 to $0.1888. The conversion was in accordance with the terms of the agreement and no gain or loss was recognized.

 

Subscription Receivable

 

On September 29, 2022, the Company granted 674,000 options to purchase shares of common stock to employees. The options expire ten years following issuance and have an exercise price of $0.15. The options vested upon issuance and have a total fair value of $104,226. On the same day, the Company issued note agreements to the employees totaling $101,100 and the employees exercised the 674,000 options. The notes bear interest of 3.15% per annum, are due on September 30, 2027, and were recorded as a subscription receivable.

 

11

 

 

On March 13, 2023, the Company granted 250,000 options to purchase shares of common stock to the Brett Gross, the Company’s prior CEO. The options expire ten years following issuance and have an exercise price of $0.067. The options vested upon issuance and have a total fair value of $16,750. On the same day, the Company issued a note agreement to the Mr. Gross totaling $16,750 and Mr. Gross exercised the 250,000 options. The note bears interest of 3.15% per annum, is due on March 15, 2028, and was recorded as a subscription receivable. On February 12, 2024, the Company signed an addendum to the January 31, 2023, promissory note to net the $16,750 subscription receivable with Mr. Gross and accrued interest of $480 with the promissory note.

 

As of October 31, 2024, and January 31, 2024, the subscription receivable was $101,100 and $117,850, respectively.

 

Stock Options

 

Qualified and non-qualified incentive stock options outstanding at October 31, 2024 are as follows:

 Schedule of Stock Option Activity

		Number of options				Weighted average exercise price per share
Outstanding, January 31, 2024			2,808,760			$	0.83
Granted			632,238				0.22
Expired			–				–
Exercised			(75,000	)			0.05
Outstanding, October 31, 2024			3,365,998			$	0.74
Exercisable, October 31, 2024			3,203,498			$	0.76

 

These options had a weighted average remaining life of 9.11 years and have an aggregate intrinsic value of $253,984 as of October 31, 2024. The aggregate intrinsic value is calculated based on the stock price of $0.178 per share as of October 31, 2024.

 

On December 4, 2023, the Company entered into a letter of understanding with a geologist for services to be provided to the Company. As compensation, the Company will pay $4,000 per month and grant the geologist 10,000 options to purchase shares of common stock upon signing the agreement and monthly stock options to purchase 4,000 shares of common stock on a month-to-month basis. The options have a strike price equal to the closing price per share on the day the options are issued, vest upon issuance and expire in three years. During the nine months ended October 31, 2024, the Company granted 54,000 options to purchase shares of common stock to geologist. The exercise price of the options ranges from $0.047 to $0.725. The total fair value of these option grants at issuance was $15,024. During the nine months ended October 31, 2024, the Company recognized $15,024 of expense related to these options.

 

On June 28, 2024, the Company granted 165,737 options to an employee. The options expire ten years following issuance and have an exercise price of $0.226. The options vest upon issuance and have a total fair value of $37,457. The Company valued the options using the Black-Scholes model with the following key assumptions: fair value stock price, $0.226, Exercise price, $0.226, Term 10 years, Volatility 178%, and Discount rate 4.36% and a dividend yield of 0%.

 

On August 23, 2024, the Company granted 75,000 options to a board member. The options expire ten years following issuance and have an exercise price of $0.16. The options vest upon issuance and have a total fair value of $12,337. The Company valued the options using the Black-Scholes model with the following key assumptions: fair value stock price, $0.226, Exercise price, $0.226, Term 6.3 years, Volatility 191%, and Discount rate 3.71% and a dividend yield of 0%.

 

During the nine months ended October 31, 2024 and 2023, we recognized $300,101 and $38,553 of compensation expense related to incentive and non-qualified stock options previously granted to officers, employees and consultants.

 

As of October 31, 2024, there was $47,901 of unrecognized share-based compensation for all share-based awards outstanding.

 

12

 

 

Warrants

 

As of October 31, 2024, there were 14,032,073 warrants to purchase shares of common stock outstanding and 13,524,541 warrants to purchase shares of common stock exercisable. The warrants have a weighted average remaining life of 1.75 years and a weighted average exercise price of $0.12 per warrant for one common share. The warrants had an aggregate intrinsic value of $1,618,975 as of October 31, 2024.

 

Stock warrants outstanding at October 31, 2024 are as follows:

 Schedule of Stock Warrants Outstanding

		Number of warrants				Weighted average exercise price per share
Outstanding, January 31, 2024			14,254,813			$	0.21
Issued			–				–
Expired			(222,740	)			1.26
Exercised			–				–
Outstanding, October 31, 2024			14,032,073			$	0.19
Exercisable, October 31, 2024			13,524,541			$	0.12

 

NOTE 6 – Derivative Liabilities

 

The embedded conversion feature in the convertible debt instruments that the Company issued (See Note 8), that became convertible during the nine months ended October 31, 2024, qualified it as a derivative instrument since the number of shares issuable under the note is indeterminate based on guidance in FASB ASC 815, Derivatives and Hedging. These convertible notes tainted all other equity linked instruments including outstanding warrants and fixed rate convertible debt on the date that the instrument became convertible.

 

The valuation of the derivative liabilities of the warrants was determined through the use of a Monte Carlo option pricing model that values the liability of the warrants based on a risk-neutral valuation where the price of the warrant is its discounted expected value. The technique applied generates a large number of possible (but random) price paths for the underlying common stock via simulation, and then calculates the associated exercise value (i.e. “payoff”) of the warrant for each path. These payoffs are then averaged and discounted to a current valuation date resulting in the fair value of the warrant.

 

The valuation of the derivative liabilities attached to the convertible debt was arrived at through the use of a Monte Carlo model that values the derivative liability within the notes. The technique applied generates a large number of possible (but random) price paths for the underlying (or underlyings) via simulation, and then calculates the associated payment value (cash, stock, or warrants) of the derivative features. The price of the underlying common stock is modeled such that it follows a geometric Brownian motion with constant drift, and elastic volatility (increasing as stock price decreases). The stock price is determined by a random sampling from a normal distribution. Since the underlying random process is the same, for enough price paths, the value of the derivative is derived from path dependent scenarios and outcomes. The features in the notes that were analyzed and incorporated into the model included the conversion features with the reset provisions, the call/redemption/prepayment options, and the default provisions. Based on these features, there are six primary events that can occur; payments are made in cash; payments are made with stock; the note holder converts upon receiving a redemption notice; the note holder converts the note; the issuer redeems the note; or the Company defaults on the note. The model simulates the underlying economic factors that influenced which of these events would occur, when they were likely to occur, and the specific terms that would be in effect at the time (i.e. stock price, conversion price, etc.). Probabilities were assigned to each variable such as redemption likelihood, default likelihood, and timing and pricing of reset events over the remaining term of the notes based on management projections. This led to a cash flow simulation over the life of the note. A discounted cash flow for each simulation was completed, and it was compared to the discounted cash flow of the note without the embedded features, thus determining a value for the derivative liabilities.

 

13

 

 

Key inputs and assumptions used to value the convertible note when it became convertible and upon settlement, and warrants upon tainting, were as follows:

 

	●	The stock projections are based on the historical volatilities for each date. The volatility of 188.8% is based on historical prices over a lookback period equivalent to the expected term of 1.8 years. The stock price projection was modeled such that it follows a geometric Brownian motion with constant drift and constant volatility, starting with the recast stock price at each valuation date;
	●	The Holder will exercise the warrant at maturity if the stock price was above the exercise price;
	●	Discount rate was based on risk free rates of 4.36% in effect based on the remaining term and date of each valuation and instrument;
	●	Dividend yield: 0%;
	●	Exercise Price: $0.04 to $16.20. $20M/number shares issued and outstanding at maturity (exercise date);
	●	Number of Options: $1M/exercise price; and
	●	The shares issued and outstanding is based on the initial 10,888,894 shares as of 10/31/21 to 51,156,228 shares as of 10/31/24 and a 2.49% growth (a lower growth from last quarter) monthly at 10/31/24 and future financing events raising $500,000 annually through the sale of common stock at a 25% discount.

 

Using the results from the model, the Company recorded a derivative liability during the nine months ended October 31, 2024 of $67,352 for the fair value of the convertible feature included in the Company’s convertible debt instruments. The derivative liability recorded for the convertible feature created a “day 1” derivative loss of $0 and a debt discount of $67,352 that is being amortized over the remaining term of the note using the effective interest rate method. Interest expense related to the amortization of this debt discount for the nine months ended October 31, 2024, was $67,352. The remaining unamortized debt discount related to the derivative liability was $0 as of October 31, 2024.

 

During the nine months ended October 31, 2024, the Company recorded a gain of $3,783,056 due to a change in the fair value of the derivative liabilities to reflect the value of the derivative liabilities for warrants as of October 31, 2024.

 

Using the results from the model, the Company recorded a derivative liability during the nine months ended October 31, 2023 of $146,368 for the fair value of the convertible feature included in the Company’s convertible debt instruments. The derivative liability recorded for the convertible feature created a “day 1” derivative loss of $0 and a debt discount of $146,368 that is being amortized over the remaining term of the note using the effective interest rate method. Interest expense related to the amortization of this debt discount for the nine months ended October 31, 2023, was $197,477. The remaining unamortized debt discount related to the derivative liability was $0 as of October 31, 2023.

 

During the nine months ended October 31, 2023, the Company recorded $156,309 due to the conversions of a portion of the Company’s convertible notes. The Company also recorded a change in the fair value of the derivative liabilities as a gain of $160,551 to reflect the value of the derivative liabilities for warrants and convertible notes as of October 31, 2023.

 

The following table sets forth a reconciliation of changes in the fair value of the Company’s derivative liabilities:

 Schedule of Changes in Fair value of Derivative Liabilities

		Nine months ended October 31,
		2024				2023
Beginning balance		$	2,547,458			$	172,393
Total gain			(3,783,056	)			(160,551	)
Settlements			(52,476	)			(156,309	)
Additions recognized as debt discount			67,352				146,368
Changes due to tainted (untainted) warrants			1,858,199				(1,901	)
Ending balance		$	637,477			$	-
Change in fair value of derivative liabilities included in earnings relating to derivatives		$	(3,783,056	)		$	(160,551	)

 

14

 

 

NOTE 7 – Long-term debt and convertible promissory notes

 

Following is a summary of convertible promissory notes:

 Schedule of Convertible Promissory Notes

		October 31, 2024				January 31, 2024
8% convertible note payable issued January 2024, due October 2024		$	-			$	110,000
10% convertible note payable issued February 2024, due November 2024			10,500				–
10% convertible note payable issued June 2024, due March 2025			66,000				–
10% convertible note payable issued August 2024, due May 2025			67,200				–
10% convertible note payable issued October 2024, due July 2025			97,200				–
Convertible note payable			240,900				110,000
Less debt discount			(39,917	)			(15,000	)
Less current portion of convertible notes			(200,983	)			(95,000	)
Long-term convertible notes payable		$	–			$	–

 

On January 12, 2024, the Company entered into a convertible promissory note with 1800 Diagonal Lending in the aggregate principal amount of $110,000 (the “January 2024 Note”). The note bears interest at 8%, with an Original Issue Discount of $10,000 plus an additional $5,000 to pay for transaction fees of the lender, matures on March 24,2024, and is convertible after 180 days into shares of the Company’s common stock at a price of 75% of the average of the lowest 5 weighted average market prices of the Company’s common stock during the 10 trading days prior to conversion. During the nine months ended October 31, 2024, the noteholder converted a total of $110,000 of the note for 867,389 shares of the Company’s common stock.

 

As of October 31, 2024, the note balance was $0. As of January 31, 2024, the note balance was $95,000, net of $15,000 discount.

 

On February 23, 2024, the Company entered into a promissory note with 1800 Diagonal Lending in the aggregate principal amount of $126,000 (the “February 2024 Note”). The note bears interest at 10%, with an Original Issue Discount of $21,000 plus an additional $5,000 to pay for transaction fees of the lender, matures on November 30, 2024. Pursuant to the terms of the Note, the outstanding principal and accrued interest on the Note shall be paid in 4 set monthly cash payments beginning six months from the effective date. The note may be prepaid with no penalty. The note allows an event of default which may be convertible into shares of the Company’s common stock as set forth therein. At any time following an event of default, the note is convertible into shares of the Company’s common stock at a price of 65% of the lowest weighted average market price of the Company’s common stock during the 10 trading days prior to conversion. During the nine months ended October 31, 2024, the Company repaid $115,500 of principal on the note. As of October 31, 2024, the note balance was $7,724, net of $2,776 discount.

 

On June 13, 2024, the Company entered into a promissory note with 1800 Diagonal Lending in the aggregate principal amount of $126,000 (the “June 2024 Note”). The note bears interest at 10%, with an Original Issue Discount of $21,000 plus an additional $5,000 to pay for transaction fees of the lender, matures on March 15, 2025. Pursuant to the terms of the Note, the outstanding principal and accrued interest on the Note shall be paid in 4 set monthly cash payments beginning six months from the effective date. The note may be prepaid with no penalty. The note allows an event of default which may be convertible into shares of the Company’s common stock as set forth therein. At any time following an event of default, the note is convertible into shares of the Company’s common stock at a price of 65% of the lowest weighted average market price of the Company’s common stock during the 10 trading days prior to conversion. As of October 31, 2024, note balance was $63,545, net of $2,455 discount.

 

On August 28, 2024, the Company entered into a promissory note with 1800 Diagonal Lending in the aggregate principal amount of $67,200 (the “August 2024 Note”). The note bears interest at 10%, with an Original Issue Discount of $11,200 plus an additional $6,000 to pay for transaction fees of the lender, matures on May 30, 2025. Pursuant to the terms of the Note, the outstanding principal and accrued interest on the Note shall be paid in 4 set monthly cash payments beginning six months from the effective date. The note may be prepaid with no penalty. The note allows an event of default which may be convertible into shares of the Company’s common stock as set forth therein. At any time following an event of default, the note is convertible into shares of the Company’s common stock at a price of 65% of the lowest weighted average market price of the Company’s common stock during the 10 trading days prior to conversion. As of October 31, 2024, note balance was $54,003, net of $13,197 discount.

 

15

 

 

On October 22, 2024, the Company entered into a promissory note with 1800 Diagonal Lending in the aggregate principal amount of $97,200 (the “October 2024 Note”). The note bears interest at 10%, with an Original Issue Discount of $16,200 plus an additional $6,000 to pay for transaction fees of the lender, matures on July 30, 2025. Pursuant to the terms of the Note, the outstanding principal and accrued interest on the Note shall be paid in 4 set monthly cash payments beginning six months from the effective date. The note may be prepaid with no penalty. The note allows an event of default which may be convertible into shares of the Company’s common stock as set forth therein. At any time following an event of default, the note is convertible into shares of the Company’s common stock at a price of 65% of the lowest weighted average market price of the Company’s common stock during the 10 trading days prior to conversion. As of October 31, 2024, note balance was $75,711, net of $21,489 discount.

 

During the nine months ended October 31, 2024 and 2023, the Company recorded debt discounts of $67,352 and $146,368, respectively, due to the derivative liabilities, and original issue debt discounts and fees paid to lender of $70,400 and $17,350, respectively, due to the convertible notes. The Company recorded amortization of these discounts of $112,835 and $197,477 for the nine months ended October 31, 2024 and 2023, respectively.

 

Notes Payable

 

On June 22, 2020, the Company received loan proceeds of $32,300 (net of a $100 loan fee) under the SBA’s Economic Injury Disaster Loan program (“EIDL”). The EIDL loan, dated June 16, 2020, bears interest at 3.75%, has a 30-year term, and is due in monthly installments of $158 beginning June 18, 2021 (extended to December 18, 2022).

 

In April 2024, the Company entered into a Premium Finance Agreement related to an insurance policy. The policy premiums total $33,500 for a one-year policy period. The Company financed $24,750 of the policy over a nine-month period. The monthly payments under the agreement are due in nine installments of $2,903, at an annual interest rate of 13.2%.

 

As of October 31, 2024, the notes payable, net balance was $40,922, which include term long notes payable of $32,400 and current portion of notes payable of $8,522, with accrued interest of $2,729. As of January 31, 2024, the note principal balance totaled $32,400, with accrued interest of $2,729, and is included in long-term debt.

 

NOTE 8 – Commitments and contingencies

 

We currently rent storage space for $105 per month in Tombstone, Arizona on a month-to-month basis.

 

We are required to pay annual rentals for Liberty Star’s federal lode mining claims for the Tombstone project in the State of Arizona. The rental period begins at noon on September 1^st through the following September 1^st and rental payments are due by the first day of the rental period. The annual rentals are $200 per claim. The rentals due by September 1, 2024 for the period from September 1, 2024 through September 1, 2025 of $15,345 have been paid.

 

We are required to pay annual rentals for our Arizona State Land Department Mineral Exploration Permits (“AZ MEP”) at our Tombstone Hay Mountain project in the State of Arizona. AZ MEP permits cost $500 per permit per year in non-refundable filing fees and are valid for 1 year and renewable for up to 5 years. The rental fee is $2.00 per acre for the first year, which includes the second year, and $1.00 per acre per year for years three through five. The minimum work expenditure requirements are $10 per acre per year for years one and two and $20 per acre per year for years three through five. If the minimum work expenditure requirement is not met the applicant can pay an equal amount in fees to the Arizona State Land Department to keep the AZ MEP permits current. The rental period begins on the date of acceptance for each permit. Rental payments are due by the first day of the rental period. We hold AZ MEP permits for 12,878.18 acres at our Tombstone project. We paid filing and rental fees for our AZ MEPs before their respective due dates in the amount of $27,264.  

 

NOTE 9 – Subsequent Events

 

The Company has evaluated subsequent events through the filing date of this Form 10-Q and determined that the following subsequent events have occurred that would require recognition in the consolidated financial statements or disclosures in the notes thereto.

 

On November 8, 2024, the Investor purchased 258,228 restricted shares of the Company’s common stock for net proceeds of $26,461 ($0.10 per share), after deducting the legal fees and clearing expenses.

 

On November 22, 2024, the Investor purchased 318,322 restricted shares of the Company’s common stock for net proceeds of $26,884 ($0.09 per share), after deducting the legal fees and clearing expenses.

 

On December 2, 2024, the Company entered into a promissory note with 1800 Diagonal Lending in the aggregate principal amount of $67,200 (the “December 2024 Note”). The note bears interest at 10%, with an Original Issue Discount of $11,200 plus an additional $6,000 to pay for transaction fees of the lender, matures on September 15, 2025. Pursuant to the terms of the Note, the outstanding principal and accrued interest on the Note shall be paid in 4 set monthly cash payments beginning six months from the effective date. The note may be prepaid with no penalty. The note allows an event of default which may be convertible into shares of the Company’s common stock as set forth therein. At any time following an event of default, the note is convertible into shares of the Company’s common stock at a price of 65% of the lowest weighted average market price of the Company’s common stock during the 10 trading days prior to conversion.

 

On December 11, 2024, the Investor purchased 213,135 restricted shares of the Company’s common stock for net proceeds of $12,675 ($0.067 per share), after deducting the legal fees and clearing expenses.

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

General

 

You should read the following discussion and analysis of our financial condition and results of operations together with the interim financial statements and related notes that are included elsewhere in this Quarterly Report on Form 10-Q and the audited consolidated financial statements and the notes to those consolidated financial statements for the fiscal year ended January 31, 2024, which were included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission on May 15, 2024 (the “2023 Annual Report”). The following discussion contains forward-looking statements regarding future events and the future results of the Company that are based on current expectations, estimates, forecasts, and projections about the industry in which the Company operates and the beliefs and assumptions of the management of the Company. See also “Cautionary Statement Regarding Forward-Looking Information”, above. Words such as “expects,” “anticipates,” “targets,” “goals,” “projects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” variations of such words, and similar expressions are intended to identify such forward-looking statements. These forward-looking statements are only predictions and are subject to risks, uncertainties and assumptions that are difficult to predict. Therefore, actual results may differ materially and adversely from those expressed in any forward-looking statements. Factors that might cause or contribute to such differences include, but are not limited to, those discussed elsewhere in this Quarterly Report and in other reports we file with the SEC. The Company undertakes no obligation to revise or update publicly any forward-looking statements for any reason, except as otherwise provided by law.

 

The following discussion is based upon our consolidated financial statements included elsewhere in this Quarterly Report, which have been prepared in accordance with U.S. generally accepted accounting principles. The preparation of these condensed consolidated interim financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingencies. In the course of operating our business, we routinely make decisions as to the timing of the payment of invoices, the collection of receivables, among other matters. Each of these decisions has some impact on the financial results for any given period. In making these decisions, we consider various factors including contractual obligations, competition, internal and external financial targets and expectations, and financial planning objectives. On an on-going basis, we evaluate our estimates, including those related to allowance for doubtful accounts, impairment of long-term assets, especially goodwill and intangible assets, assumptions used in the valuation of stock-based compensation, and litigation. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

 

Certain capitalized terms used below but not otherwise defined, are defined in, and shall be read along with the meanings given to such terms in, the notes to the unaudited consolidated financial statements of the Company for the quarters ended October 31, 2024 and 2023, above.

 

References to our websites and those of third parties below are for information purposes only and, unless expressly stated below, we do not desire to incorporate by reference into this Report information in such websites.

 

Unless the context otherwise requires, references in this Report to “we,” “us,” “our,” the “Registrant”, the “Company,” “Liberty Star” and “Liberty Star Uranium & Metals Corp.” refer to Liberty Star Uranium & Metals Corp.

 

In addition:

 

	●	“Exchange Act” refers to the Securities Exchange Act of 1934, as amended;
	●	“SEC” or the “Commission” refers to the United States Securities and Exchange Commission; and
	●	“Securities Act” refers to the Securities Act of 1933, as amended.

 

 

Available Information

 

We file annual, quarterly, and current reports, proxy statements and other information with the SEC. The SEC maintains an Internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC like us at https://www.sec.gov . Copies of documents filed by us with the SEC (including exhibits) are also available from us without charge, upon oral or written request to our Secretary, who can be contacted at the address and telephone number set forth on the cover page of this Report.

 

The following discussion of the Company’s historical performance and financial condition should be read together with the financial statements and related notes included herein. This discussion contains forward-looking statements based on the views and beliefs of our management, as well as assumptions and estimates made by our management. These statements by their nature are subject to risks and uncertainties, and are influenced by various factors. As a consequence, actual results may differ materially from those in the forward-looking statements. See “Item 1A. Risk Factors” included herein for the discussion of risk factors and see “Cautionary Statement Regarding Forward-Looking Statements” for information on the forward-looking statements included below.

 

The following discussion is based upon our financial statements included elsewhere in this Form 10-Q, which has been prepared in accordance with U.S. generally accepted accounting principles. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingencies.

 

Introduction

 

Business Development

 

The following Management’s Discussion and Analysis of Financial Condition and Results of Operations is intended to help the reader understand the results of operations and financial condition of our Company. Management’s Discussion and Analysis of Financial Condition and Results of Operations is provided as a supplement to, and should be read in conjunction with, our consolidated financial statements and the accompanying notes to the consolidated financial statements.

 

Liberty Star Uranium & Metals Corp. was formerly Liberty Star Gold Corp. and formerly Titanium Intelligence, Inc. (“Titanium”). Titanium was incorporated on August 20, 2001, under the laws of the State of Nevada. On February 5, 2004, we commenced operations in the acquisition and exploration of mineral properties business. Big Chunk Corp. (“Big Chunk”) was our wholly owned subsidiary and was incorporated on December 14, 2003, in the State of Alaska. Big Chunk is engaged in the acquisition and exploration of mineral properties business in the State of Alaska. Big Chunk was dissolved on June 3, 2019. Redwall Drilling Inc. (“Redwall”) was our wholly owned subsidiary and was incorporated on August 31, 2007, in the State of Arizona. Redwall performed drilling services on our mineral properties. Redwall ceased drilling activities in July 2008 and was dissolved on March 30, 2010. In April 2007, we changed our name to Liberty Star Uranium & Metals Corp (“Liberty Star”) to reflect our current general exploration for base and precious metals. We are in the exploration phase of operations and have not generated any revenues from operations.

 

In October 2014, we formed our wholly owned subsidiary, Hay Mountain Holdings LLC (“HMH”) (formerly known as Hay Mountain Super Project LLC), to serve as the primary holding company for development of the potential ore bodies encompassed in the Hay Mountain area of interest in Arizona. On April 11, 2019, we formed a new subsidiary named Earp Ridge Mines LLC, wholly owned by Hay Mountain Holdings LLC, intended for engagement with future venture partners.

 

On August 13, 2020, the Company formed Red Rock Mines, LLC, an Arizona corporation, as a wholly owned subsidiary of Hay Mountain Holdings, LLC.

 

Our Current Business

 

We are engaged in the acquisition and exploration of mineral properties in the state of Arizona and the Southwest USA. Claims in the state of Arizona are held in the name of Liberty Star. We use the term “Super Project” to indicate a project in which numerous mineral targets have been identified, any one or more of which could potentially contain commercially viable quantities of minerals. Our significant projects are described below.

 

Tombstone Super Project (“Tombstone”): Tombstone is a large and ancient (72 million years before the present – or Laramide in age) volcanic structure – a caldera. The US Geological Survey caldera experts conclude this is correct. Subsequently, more than seventeen calderas of various ages have been identified in Arizona by the US Geological survey, the Arizona Geological Survey and others. Such calderas of Laramide age are all associated with porphyry alteration and copper and associated mineralization; many of these have become very large copper mines. Advanced technology has indicated that alteration associated mineralization at Tombstone is much more extensive than originally thought. This alteration lies largely under cover and is indicated by geochemistry, geophysics and projection of known geology into covered areas.

 

 

All the properties summarized below are considered as “Exploration stage properties” under the definition of SK1300 and are considered “non-material properties.”

 

The Hay Mountain Property: The Hay Mountain Property is located 6.5 miles southeast of Tombstone where we hold 35 Arizona State Mineral Exploration Permits (MEPs) covering (12,878.18 acres) or 20.12 square miles, and 93 federal lode mining claims covering (1,594.68 acres) or 2.49 square miles and is accessible by Hwy 80, Davis Rd. and Wild West Road.

 

At Hay Mountain, we plan to ascertain whether the Hay Mountain lode mining claims and AZ MEPs possess commercially viable deposits of copper, gold, molybdenum, silver, zinc, rare earth metals and other valuable metals. We have a phased exploration plan that involves diamond drilling of multiple holes over targets determined by analysis of geochemical sampling and ZTEM electromagnetic and magnetic survey. Initial phase 1 drilling is planned to take approximately one year. Should results indicate the viability of the property, additional phased work, both exploration and development, is planned over the course of seven total years to define the nature and size of any potential ore bodies and move toward mining. Any exploration plans are dependent on acquiring suitable funding. No part of the phased program is currently funded.

 

From early December 2023 until March 4, 2024, we drilled the first two holes of our Phase 1 drilling project in the Hay Mountain Property. Hole HM-23-01 was 1,500’ deep and hole HM-23-02 was 3,437’ deep. The first two holes do not provide a sufficient data set to prepare an estimate of the overall mineral resources under S-K 1300. These holes were designed as a ‘test of concept’ to check the results of the previous geochemical and geophysical work done by us in the past. Hole HM-23-01 was not drilled deep enough to encounter alteration nor mineralization and will be deepened at a future date. Hole HM-23-02 did encounter alteration and mineralization associated with a copper porphyry system, with trace level copper values found in the intrusive rock to 0.1%. Further drilling will be required in this area to begin to understand the scope and source of that mineralization.

 

Holes 01 and 02 are the first two holes of a much larger phase of planned drilling to be conducted in 2024. A full technical report on the drilling program will be prepared at the conclusion of phase one.

 

On November 25, 2020, the Company received approval from the Arizona State Land Department for 5 additional MEP’s covering 2,369.15 acres for a total of 16,662.10 acres or 26.03 square miles at our Hay Mountain Property.

 

From July 14th to August 5^th, 2020, field mapping was conducted on the Hay Mountain Property, located 7 km southeast of Tombstone, in Cochise County, Arizona. The purpose of mapping was to identify alteration and veining associated with an inferred porphyry copper system at depth, determine the extent of hydrothermal alteration, and comment on the possible timing of emplaced mineralization. Mapping was conducted at 1:10,000 scale and a total of 183 carbonate vein samples were taken for XRF analysis and UV fluorescence response.

 

Robbers Roost exploration property: On June 16, 2020, the Company acquired 2 Mineral Exploration Permits (“MEP”) covering 240 acres at Robbers Roost. Which is located 5.89 miles west of the Hay Mountain Project. While the Robbers Roost MEP area is new to the Company, it has been explored previously by several exploration companies, in the 1970’s and 1990’s, and recently has received significant interest by others operating in the area. Drilling by ASARCO indicates “the presence of a granodioritic porphyry intrusive at depth below the alteration zone. The intrusive is characterized by porphyry copper style alteration and mineralization.” (JB Nelson, “Robbers’ Roost Summary Report,” 1995, p. 2 http://docs.azgs.az.gov/SpecColl/2008-01/2008-01-0103.pdf)

 

Red Rock Canyon exploration property: As of mid-March 2024, the Company is currently conducting a statistical sampling program on the property. Channel samples are cut using a handheld rock saw across the jasperoid lenses at measured lengths and spacing between the channels. QA/QC samples are being inserted into the sample stream as per “Industry Standard”. Results are pending.

 

On August 20, 2021, the Company executed a financing agreement for the purpose of drilling for the Red Rock Canyon Gold Property in Cochise County, Arizona. The agreement allowed for a $1,000,000 common stock purchase agreement (the “Purchase Agreement”) and a $1,000,000 warrant agreement (the “Warrant Agreement,” together “the Agreements”) with Triton Funds LP (“Triton”) of San Diego, California under a Form S-1 registration now effective. As of December 31, 2022, the purchase agreement expired.

 

 

On May 26, 2021, the Company announced the public release of geochemical assay results prepared by ALS/USA Inc. The Company noted in its news release issued May 21, 2021 that the results were forthcoming. Previously released geochemical assay results from October 2020 and February 2021 can be viewed on the Liberty Star Minerals website. This set of results strongly aligns with previous assay results indicating that the Red Rock portion of the Hay Mountain Project is a potential gold property.

 

On March 15, 2021, the Company announced the release of more rock chip assay results from the Red Rock Canyon area located within the Hay Mountain Project. 28 samples were submitted to the ALS/USA Inc. Tucson location with results returned to the Company February 6, 2021. This set of samples are within and outside of the original study area and expand on the October 2020 geochemical sampling undertaken on MEP land within the Company’s Red Rock Canyon holdings.

 

On November 11, 2020, the Company announced the identification of potentially exploitable gold mineralization on its recently acquired Arizona State Land Department Mineral Exploration Permits. Preliminary surface exploration on the Red Rock MEPs advances the Company’s knowledge of the porphyry system signature associated with magnetic highs at, and adjacent to the north of, Target 1, and represent the expansion of biogeochemical, surface rock sampling, and x-ray fluorescence (“XRF”) work continuing at Target 1 and on the anticipated gold halo likely associated with the indicated porphyry center. The Company discovered multiple outcrops of intensely silicified rock in the initial observational field work. These outcrops generally occur in linear features several feet in thickness with multiple features oriented en-echelon with interstitial host country rock of varying horizontal dimension. These outcrops contain densely distributed jasperoids, which, when sampled yield what the Company believes are potentially economically exploitable concentrations of gold. There was a total of 23 representative (1 to 2 kg) rock sample assays. These assays demonstrate gold concentrations ranging from below detection limits of 0.05 ppm in country rock surrounding certain outcrops to a high of 13.55 ppm in direct outcrop samples. Of the 23 assayed samples, nine (9) show gold concentrations of 0.95 ppm or more.

 

The Tombstone exploration property: The Tombstone exploration property consists of nine claims that are undeveloped. However, significant amounts of aeromagnetic surveys, IP (Induced Polarization Surveys), geologic mapping by the USGS and others, and geochemical surveys including soil, rock and vegetation sampling have been conducted at various times by various parties, over the last 60 years. When compiled and analyzed these various data suggest a compelling series of anomalies that are typical of buried, dirt and rock covered porphyry copper system(s). Below is a summary of prior exploration activities performed on our Tombstone claims: Technical Report: In mid-March 2011, Liberty Star contracted SRK to prepare three (3) Technical studies and Reports in a form similar to mineral reports prescribed under NI 43-101. Members of SRK’s engineering/scientific staff supervised by a Qualified Person as defined under NI 43-101 and SRK’s Tucson Office Principal Geologist, Corolla Hoag, and geologist Dr. Jan Rasmussen have visited the Tombstone property.

 

Title to mineral claims involves certain inherent risks due to difficulties in determining the validity of certain claims, as well as potential for problems arising from the frequently ambiguous conveyancing history characteristic of many mineral properties. We have investigated title to all the Company’s mineral properties and, to the best of its knowledge, title to all properties retained are in good standing.

 

The mineral resource business generally consists of three stages: exploration, development and production. Mineral resource companies that are in the exploration stage have not yet found mineral resources in commercially exploitable quantities and are engaged in exploring land in an effort to discover them. Mineral resource companies that have located a mineral resource in commercially exploitable quantities and are preparing to extract that resource are in the development stage, while those engaged in the extraction of a known mineral resource are in the production stage. We have not found any mineral resources in commercially exploitable quantities.

 

There is no assurance that a commercially viable mineral deposit exists on any of our properties, and further exploration is required before we can evaluate whether any exist and, if so, whether it would be economically feasible to develop or exploit those resources. Even if we complete our current exploration program and we are successful in identifying a mineral deposit, we would be required to spend substantial funds on further drilling and engineering studies before we could know whether that mineral deposit will constitute a commercially viable mineral deposit, known as an “ore reserve.”

 

 

SK 1300 Regulation

 

Liberty Star has performed many hours of field work mapping and sampling on our Red Rock Canyon Gold Project and although we do not have drilling core to prove results, we have through analysis of Geochem sampling, evidence of an anomaly.

 

To date, we have not generated any revenues. Our ability to pursue our business plan and generate revenues is subject to our ability to obtain additional financing, and we cannot give any assurance that we will be able to do so.

 

Results of Operations

 

Results of Operations for the Three-Month Periods Ended October 31, 2024 and 2023

 

We had net income of $926,992 for the three months ended October 31, 2024, compared to a net loss of $252,609 for the three months ended October 31, 2023. The change in net loss was primarily due to a change in derivative liability.

 

During the three months ended October 31, 2024, we had a decrease of $69,804 in geological and geophysical expense compared to the three months ended October 31, 2023, due primarily to a decrease in geologist fees and filing fees for the three-month period. During the three months ended October 31, 2024, we had an increase of $1,069 in salaries and benefit expense compared to the three months ended October 31, 2023, due to an increase in wages, benefits and reimbursements. During the three months ended October 31, 2024, we had an increase of $12,787 in professional services compared to the three months ended October 31, 2023, due primarily to increases in the legal and audit fees. We had an increase in general and administrative expenses of $84,271 during the three months ended October 31, 2024, as compared to the three months ended October 31, 2023 which was primarily due to an increase in stock-based compensation. We had a decrease in interest expense of $4,748 during the three months ended October 31, 2024, as compared to the three months ended October 31, 2023. We had a gain of $1,289,458 and $86,112 on change in fair value of derivative liability for the three months ended October 31, 2024, and 2023, respectively.

 

Results of Operations for the Nine-Month Periods Ended October 31, 2024 and 2023

 

We had net income of $2,387,518 for the nine months ended October 31, 2024, compared to a net loss of $574,567 for the nine months ended October 31, 2023. The change in net loss was primarily due to a change in derivative liability.

 

During the nine months ended October 31, 2024, we had an increase of $284,195 in geological and geophysical expense compared to the nine months ended October 31, 2023, due primarily to an increase in geologist fees and filing fees for the nine-month period. During the nine months ended October 31, 2024, we had an increase of $24,386 in salaries and benefit expense compared to the nine months ended October 31, 2023, due to an increase in wages, benefits and reimbursements. During the nine months ended October 31, 2024, we had an increase of $67,655 in professional services compared to the nine months ended October 31, 2023, due primarily to increase in legal and audit fees. We had an increase in general and administrative expenses of $313,900 during the nine months ended October 31, 2024, as compared to the nine months ended October 31, 2023, which was primarily due to an increase in stock-based compensation. We had a decrease in interest expense of $29,199 during the nine months ended October 31, 2024, as compared to the nine months ended October 31, 2023, due primarily to a decrease in notes payable and convertible notes payable. We had a gain of $3,783,056 and $160,551 on change in fair value of derivative liability for the nine months ended October 31, 2024, and 2023, respectively.

 

Liquidity and Capital Resources

 

We had cash and cash equivalents in the amount of $27,158 as of October 31, 2024. We had a working capital deficit of $1,966,502 as of October 31, 2024. We used cash in operating activities of $817,627 for the nine months ended October 31, 2024.

 

Advances

 

During the nine months ended October 31, 2024, the Company received advances of $210,000 from Pete O’Heeron, Chairman of the Board, and repaid $25,000 of advances. The advances are unsecured, non-interest bearing and is payable on demand. As of October 31, 2024, the advances related party balance was $185,000.

 

 

Notes payable, related party

 

On January 25, 2024, the Company entered into a promissory note with Pete O’Heeron, Chairman of the Board, for $250,000 and received cash proceeds. The note bears interest at 10% and matures on January 25, 2025.

 

On February 13, 2024, the Company entered into a promissory note with Pete O’Heeron, Chairman of the Board, in the aggregate principal amount of $210,000. The note bears interest at 10% matures on February 13, 2025.

 

On April 3, 2024, the Company entered into a promissory note with Pete O’Heeron, Chairman of the Board, in the aggregate principal amount of $75,000. The note bears interest at 10% matures on April 3, 2025.

 

On May 1, 2024, the Company entered into a promissory note with Pete O’Heeron, Chairman of the Board, in the aggregate principal amount of $45,000. The note bears interest at 10% matures on May 1, 2025.

 

On May 20, 2024, the Company entered into a promissory note with Pete O’Heeron, Chairman of the Board, in the aggregate principal amount of $67,000. The note bears interest at 10% matures on May 20, 2025.

 

On July 5, 2024, the Company entered into a promissory note with Pete O’Heeron, Chairman of the Board, in the aggregate principal amount of $70,000. The note bears interest at 10% matures on July 5, 2025.

 

Convertible promissory notes

 

We have issued the following convertible promissory notes in private placements of our securities to institutional investors pursuant to exemptions from registration set out in Rule 506 of Regulation D under the Securities Act.

 

On January 12, 2024, the Company entered into a convertible promissory note with 1800 Diagonal Lending in the aggregate principal amount of $110,000 (the “January 2024 Note”). The note bears interest at 8%, with an Original Issue Discount of $10,000 plus an additional $5,000 to pay for transaction fees of the lender, matures on March 24,2024, and is convertible after 180 days into shares of the Company’s common stock at a price of 75% of the average of the lowest 5 weighted average market prices of the Company’s common stock during the 10 trading days prior to conversion. During the nine months ended October 31, 2024, the noteholder converted a total of $110,000 of the note for 867,389 shares of the Company’s common stock. As of October 31, 2024, the note balance was $0. As of January 31, 2024, the note balance was $95,000, net of $15,000 discount.

 

On February 23, 2024, the Company entered into a promissory note with 1800 Diagonal Lending in the aggregate principal amount of $126,000 (the “February 2024 Note”). The note bears interest at 10%, with an Original Issue Discount of $21,000 plus an additional $5,000 to pay for transaction fees of the lender, matures on November 30, 2024. Pursuant to the terms of the Note, the outstanding principal and accrued interest on the Note shall be paid in 4 set monthly cash payments beginning six months from the effective date. The note may be prepaid with no penalty. The note allows an event of default which may be convertible into shares of the Company’s common stock as set forth therein. At any time following an event of default, the note is convertible into shares of the Company’s common stock at a price of 65% of the lowest weighted average market price of the Company’s common stock during the 10 trading days prior to conversion. During the nine months ended October 31, 2024, the Company repaid $115,500 of principal on the note. As of October 31, 2024, the note balance was $7,724, net of $2,776 discount.

 

On June 13, 2024, the Company entered into a promissory note with 1800 Diagonal Lending in the aggregate principal amount of $126,000 (the “June 2024 Note”). The note bears interest at 10%, with an Original Issue Discount of $21,000 plus an additional $5,000 to pay for transaction fees of the lender, matures on March 15, 2025. Pursuant to the terms of the Note, the outstanding principal and accrued interest on the Note shall be paid in 4 set monthly cash payments beginning six months from the effective date. The note may be prepaid with no penalty. The note allows an event of default which may be convertible into shares of the Company’s common stock as set forth therein. At any time following an event of default, the note is convertible into shares of the Company’s common stock at a price of 65% of the lowest weighted average market price of the Company’s common stock during the 10 trading days prior to conversion. As of October 31, 2024, note balance was $63,545, net of $2,455 discount.

 

 

On August 28, 2024, the Company entered into a promissory note with 1800 Diagonal Lending in the aggregate principal amount of $67,200 (the “August 2024 Note”). The note bears interest at 10%, with an Original Issue Discount of $11,200 plus an additional $6,000 to pay for transaction fees of the lender, matures on May 30, 2025. Pursuant to the terms of the Note, the outstanding principal and accrued interest on the Note shall be paid in 4 set monthly cash payments beginning six months from the effective date. The note may be prepaid with no penalty. The note allows an event of default which may be convertible into shares of the Company’s common stock as set forth therein. At any time following an event of default, the note is convertible into shares of the Company’s common stock at a price of 65% of the lowest weighted average market price of the Company’s common stock during the 10 trading days prior to conversion. As of October 31, 2024, note balance was $54,003, net of $13,197 discount.

 

On October 22, 2024, the Company entered into a promissory note with 1800 Diagonal Lending in the aggregate principal amount of $97,200 (the “October 2024 Note”). The note bears interest at 10%, with an Original Issue Discount of $16,200 plus an additional $6,000 to pay for transaction fees of the lender, matures on July 30, 2025. Pursuant to the terms of the Note, the outstanding principal and accrued interest on the Note shall be paid in 4 set monthly cash payments beginning six months from the effective date. The note may be prepaid with no penalty. The note allows an event of default which may be convertible into shares of the Company’s common stock as set forth therein. At any time following an event of default, the note is convertible into shares of the Company’s common stock at a price of 65% of the lowest weighted average market price of the Company’s common stock during the 10 trading days prior to conversion. As of October 31, 2024, note balance was $75,711, net of $21,489 discount.

 

Summary of Cash Flows

 

Cash used in operating activities

 

Net cash used in operating activities was $817,627 and $424,303 for the nine months ended October 31, 2024, and 2023, respectively, and mainly included payments made for geological and geophysical costs, compensation, and professional fees to our consultants, attorneys and accountants.

 

Cash provided by financing activities

 

Net cash provided by financing activities was $772,686 for the nine months ended October 31, 2024, related to the proceeds from convertible promissory notes and proceeds from notes payable, related party, which were offset by the repayment of advances, related party. Net cash used in financing activities was approximately $1,113,424 for the nine months ended October 31, 2023, related to the proceeds from the issuance of common stock and warrants in a private placement, convertible promissory notes and receipt of subscription receivable, which were offset by the repayment of notes payable.

 

Critical Accounting Policies

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates, assumptions and judgments that affect the amounts reported in the consolidated financial statements, including the notes thereto. We consider critical accounting policies to be those that require more significant judgments and estimates in the preparation of our consolidated financial statements, including the following: long lived assets; intangible assets valuations; and income tax valuations. Management relies on historical experience and other assumptions believed to be reasonable in making its judgment and estimates. Actual results could differ materially from those estimates.

 

Management believes its application of accounting policies, and the estimates inherently required therein, are reasonable. These accounting policies and estimates are periodically reevaluated, and adjustments are made when facts and circumstances dictate a change.

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk.

 

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item.

 

Item 4. Controls and Procedures.

 

The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

 

 

As required by Rule 13a-15 under the Exchange Act, our management has evaluated the effectiveness of the design and operation of our disclosure controls and procedures at October 31, 2024, which is the end of the fiscal quarter covered by this report. This evaluation was carried out by Ms. Patricia Madaris, our principal executive officer and principal financial officer. Based on this evaluation, Ms. Patricia Madaris has concluded that our disclosure controls and procedures were not effective as at the end of the period covered by this report. Given the size of our current operation and existing personnel, the opportunity to implement internal control procedures that segregate accounting duties and responsibilities is limited. Until the organization can increase in size to warrant an increase in personnel, formal internal control procedures will not be implemented until they can be effectively executed and monitored. Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed by our company in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by our company in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our principal executive officer and principal financial officer, to allow timely decisions regarding required disclosure.

 

Management believes that despite our material weaknesses set forth above, our consolidated financial statements for the quarter ended October 31, 2024, are fairly stated, in all material respects, in accordance with U.S. GAAP.

 

Changes in Internal Control over Financial Reporting

 

During the quarter ended October 31, 2024, there were no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

Limitations on Effectiveness of Controls and Procedures

 

In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and that management is required to apply its judgment in evaluating the benefits of possible controls and procedures relative to their costs.

 

PART II - OTHER INFORMATION

 

Item 1. Legal Proceedings

 

There are no pending or threatened legal proceedings involving our company. However, from time to time, we may become involved in various legal proceedings that arise in the ordinary course of business. Those claims, even if lacking merit, could result in the expenditure by us of significant financial and managerial resources. We may become involved in material legal proceedings in the future.

 

Item 1A. Risk Factors

 

Reference is made to Part I, Item 1A, “Risk Factors” included in our 2023 Annual Report for information concerning risk factors, which should be read in conjunction with the factors set forth in “Cautionary Statement Regarding Forward-Looking Information” of this Report. There have been no material changes with respect to the risk factors disclosed in our 2023 Annual Report, except as discussed below. You should carefully consider such factors in the 2023 Annual Report, which could materially affect our business, financial condition or future results. The risks described in the 2023 Annual Report are not the only risks facing our company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially and adversely affect our business, financial condition and/or operating results.

 

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

Recent Sales of Unregistered Securities

 

On August 5, 2024, the Company entered into a twelve-month stock compensation and subscription agreement with an investor relations firm that includes the issuance of 225,000 shares of restricted common stock with a fair value of $45,000.

 

On August 13, 2023, the Company issued a total of 145,560 shares of our common stock for conversions of $20,000 in principal for the January 2024 Note at the exercise price $0.1374.

 

On August 22, 2023, the Company issued a total of 163,934 shares of our common stock for conversions of $20,000 in principal for the January 2024 Note at the exercise price $0.1220.

 

On September 3, 2024, the Company issued a total of 191,471 shares of our common stock for conversions of $22,000 in principal on convertible notes payable at the exercise price of $0.1149.

 

On September 12, 2024, the Company issued a total of 181,043 shares of our common stock for conversions of $13,000 in principal and $4,400 of interest on convertible notes payable at the exercise price of $0.09611.

 

On September 25, 2024, the Company issued 100,000 shares of common stock to the Investor as a commitment fee. The shares were valued at approximately $20,000.

 

On October 24, 2024, the Investor purchased 79,976 restricted shares of the Company’s common stock for net proceeds of $6,414 ($0.08 per share), after deducting the legal fees and clearing expenses.

 

On November 8, 2024, the Investor purchased 258,228 restricted shares of the Company’s common stock for net proceeds of $26,461 ($0.10 per share), after deducting the legal fees and clearing expenses.

 

On November 22, 2024, the Investor purchased 318,322 restricted shares of the Company’s common stock for net proceeds of $26,884 ($0.09 per share), after deducting the legal fees and clearing expenses.

 

On December 11, 2024, the Investor purchased 213,135 restricted shares of the Company’s common stock for net proceeds of $12,675 ($0.067 per share), after deducting the legal fees and clearing expenses.

 

Purchases of Equity Securities by the Issuer and Affiliated Purchasers

 

None.

 

Item 3. Defaults Upon Senior Securities.

 

None.

 

Item 4. Mine Safety Disclosures.

 

Under Section 1503(a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act and under Item 104 of Regulation S-K, each operator of a coal or other mine is required to include disclosures regarding certain mine safety results in its periodic reports filed with the SEC. The operation of our mine(s) that may be developed in the future would be subject to regulation by the federal Mine Safety and Health Administration (“MSHA”) under the Federal Mine Safety and Health Act of 1977. We do not own any mines in the United States and as a result, this information is not required.

 

Item 5. Other Information.

 

(c) Rule 10b5-1 Trading Plans. Our directors and executive officers may from time to time enter into plans or other arrangements for the purchase or sale of our shares that are intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or may represent a non-Rule 10b5-1 trading arrangement under the Exchange Act. During the quarter ended October 31, 2024, none of the Company’s directors or officers (as defined in Rule 16a-1(f)) adopted or terminated any contract, instruction or written plan for the purchase or sale of Company securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any “non-Rule 10b5-1 trading arrangement.”

 

 

Item 6. Exhibits

 

Exhibit Number		Description of Exhibit
3.1		Articles of Incorporation (incorporated by reference to Exhibit 3.1 to our registration statement on Form SB-2, filed with the SEC on May 14, 2002).
3.2		Bylaws (incorporated by reference to Exhibit 3.2 to our quarterly report on Form 10-QSB, filed with the SEC on December 14, 2007).
3.3		Certificate of Change to Authorized Capital (incorporated by reference to Exhibit 3.1 to our current report on Form 8-K, filed with the SEC on September 2, 2009).
3.4		Articles of Merger (incorporated by reference to Exhibit 3.4 to our annual report on Form 10-KSB, filed with the SEC on March 31, 2004).
3.5		Amendments to Articles of Incorporation and Bylaws (incorporated by reference to Exhibit 3.8 and 3.9 to our current report on Form 8-K/A, filed with the SEC on August 10, 2020).
3.6		Certificate of Change pursuant to NRS 78.209 dated February 25.2021 (incorporated by reference to exhibit 10.2 and filed with the SEC on February 25, 2021).
3.7		Certificate of Amendment to increase authorized shares dated October 6, 2021 (incorporated by reference to Exhibit 3.24 and filed with the SEC on October 6, 2021).
3.8		Certificate of Amendment to increase authorized Common & Class A Common shares dated October 28, 2022 (incorporated by reference to Exhibit 3.25 and filed with the SEC on October 28, 2022).
3.9		Certificate of Amendment to increase Class A Common shares dated February 6, 2023 (incorporated by reference to Exhibit 3.41 and filed with the SEC on February 6, 2023).
10.1		Convertible Promissory Note issued to Power Up Lending Group Ltd. dated October 20, 2020 (incorporated by reference to Exhibit 3.11 to our current report on Form 8-K, filed with the SEC on October 27, 2020).
10.2		Convertible Promissory Note issued to Redstart Holdings Corp. dated April 23, 2021 (incorporated by reference to Exhibit 3.14 to our current report on Form 8-K, filed with the SEC on April 27, 2021).
10.3		Convertible Promissory Note issued to Redstart Holdings Corp. dated May 11, 2021 (incorporated by reference to Exhibit 3.16 to our current report on Form 8-K, filed with the SEC on May 17, 2021).
10.4		Convertible Promissory Note issued to Geneva Roth Remark Holdings Inc. dated October 8, 2021 (incorporated by reference to Exhibit 3.25 to our current report on Form 8-K, filed with the SEC on October 14, 2021).
10.5		Convertible Promissory Note issued to Sixth Street Lending, LLC, dated November 15, 2021 (incorporated by reference to Exhibit 3.27 to our current report on Form 8-K, filed with the SEC on November 23, 2021).
10.6		Convertible Promissory Note issued to Sixth Street Lending, LLC, dated December 21, 2021 (incorporated by reference to Exhibit 3.29 to our current report on Form 8-K, filed with the SEC on December 29, 2021).
10.7		Convertible Promissory Note issued to Sixth Street Lending LLC dated February 7, 2022 (incorporated by reference to Exhibit 3.31 to our current report on form 8-K, filed with the SEC on February 14, 2022).
10.8		Convertible Promissory Note issued to Sixth Street Lending LLC dated April 25, 2022 (incorporated by reference to Exhibit 3.33 to our current report on form 8-K, filed with the SEC on April 2, 2022).
10.9		Convertible Promissory Note issued to 1800 Diagonal Lending LLC dated July 14, 2022 (incorporated by reference to Exhibit 3.33 to our current report on form 8-K, filed with the SEC on July 22, 2022).
10.10		Convertible Promissory Note issued to 1800 Diagonal Lending LLC dated September 28, 2022 (incorporated by reference to Exhibit 3.35 to our current report on form 8-K, filed with the SEC on October 6, 2022).
10.11		Convertible Promissory Note issued to 1800 Diagonal Lending LLC dated November 23, 2022 (incorporated by reference to Exhibit 3.37 to our current report on form 8-K, filed with the SEC on December 9, 2022).
10.12		Convertible Promissory Note issued to 1800 Diagonal Lending LLC dated February 2, 2023 (incorporated by reference to Exhibit 3.39 to our current report on form 8-K, filed with the SEC on February 7, 2023).
10.13		Convertible Promissory Note issued to 1800 Diagonal Lending LLC dated March 24, 2023, (incorporated by reference to Exhibit 3.42 to our current report on form 8-K, filed with the SEC on March 29, 2023).
10.14		Convertible Promissory Note issued to 1800 Diagonal Lending LLC dated January 12, 2024, (incorporated by reference to Exhibit 3.44 to our current report on form 8-K, filed with the SEC on January 19, 2024).
10.15		Promissory Note defaulting to conversion issued to 1800 Diagonal Lending LLC dated February 23, 2024, (incorporated by reference to Exhibit 3.46 to our current report on form 8-K, filed with the SEC on February 28, 2024).
10.16		Promissory Note defaulting to conversion issued to 1800 Diagonal Lending LLC dated June 13, 2024, (incorporated by reference to Exhibit 3.48 to our current report on form 8-K, filed with the SEC on June 17, 2024).
10.17		Promissory Note defaulting to conversion issued to 1800 Diagonal Lending LLC dated August 28, 2024, (incorporated by reference to Exhibit 3.50 to our current report on form 8-K, filed with the SEC on August 28, 2024).
10.18		Financing & Registration GHS Investment LLC Agreements up to $10M dated September 25, 2024 (incorporated by reference to Exhibit 10.18 & 10.19 to our current report on form 8K, filed with the SEC on October 1, 2024).
10.19		Promissory Note defaulting to conversion issued to 1800 Diagonal Lending LLC dated October 22, 2024, (incorporated by reference to Exhibit 3.52 to our current report on form 8-K, filed with the SEC on October 22, 2024).
10.20		Bridge Note defaulting to conversion issued to 1800 Diagonal Lending LLC dated December 2, 2024, (incorporated by reference to Exhibit 3.54 to our current report on form 8-K, filed with the SEC on December 2, 2024).
31.1*		Section 302 Certification under Sarbanes-Oxley Act of 2002 of Chief Executive Officer and Chief Financial Officer
32.1**		Section 906 Certification under Sarbanes-Oxley Act of 2002 of Chief Executive Officer and Chief Financial Officer
101.INS*		Inline XBRL INSTANCE DOCUMENT
101.SCH*		Inline XBRL TAXONOMY EXTENSION SCHEMA
101.CAL*		Inline XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
101.DEF*		Inline XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
101.LAB*		Inline XBRL TAXONOMY EXTENSION LABEL LINKBASE
101.PRE*		Inline XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
104*		Inline XBRL for the cover page of this Quarterly Report on Form 10-Q, included in the Exhibit 101 Inline XBRL Document Set

 

* Filed herewith.

** Furnished herewith.

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

LIBERTY STAR URANIUM & METALS CORP.
By:	/s/ Patricia Madaris
	Patricia Madaris,
	Interim Chief Executive Officer and Chief Financial Officer
	(Principal Executive Officer and Principal Financial Officer/Accounting Officer)

 

Date: December 16, 2024

 

 

Exhibit 31.1

 

CERTIFICATION

 

I, Patricia Madaris, certify that:

 

1.	I have reviewed this Quarterly Report on Form 10-Q of Liberty Star Uranium & Metals Corp.
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.	I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in the Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

	(a)	designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
	(b)	designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
	(c)	evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
	(d)	disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.	I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

	(a)	all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
	(b)	any fraud, whether or not material, which involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

 

Date: December 16, 2024

 

By:	/s/ Patricia Madaris
	Patricia Madaris,
	Interim Chief Executive Officer and Chief Financial Officer
	(Principal Executive Officer and Principal Financial/Accounting Officer)

 

 

Exhibit 32.1

 

CERTIFICATION PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

The undersigned, Patricia Madaris, hereby certifies, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1)	the quarterly report on Form 10-Q of Liberty Star Uranium & Metals Corp. for the period ended October 31, 2024 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)	the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Liberty Star Uranium & Metals Corp.

 

Dated: December 16, 2024

 

By:	/s/ Patricia Madaris
	Patricia Madaris,
	Interim Chief Executive Officer and Chief Financial Officer
	(Principal Executive Officer and Principal Financial Officer and Principal Accounting Officer)

 

v3.24.4

Cover - shares	9 Months Ended
	Oct. 31, 2024	Dec. 16, 2024
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Oct. 31, 2024
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2025
Current Fiscal Year End Date	--01-31
Entity File Number	000-50071
Entity Registrant Name	LIBERTY STAR URANIUM & METALS CORP.
Entity Central Index Key	0001172178
Entity Tax Identification Number	90-0175540
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	2 East Congress Street Ste. 900
Entity Address, City or Town	Tucson
Entity Address, State or Province	AZ
Entity Address, Postal Zip Code	85701
City Area Code	520
Local Phone Number	425-1433
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		51,945,913

v3.24.4

Consolidated Balance Sheets (Unaudited) - USD ($)	Oct. 31, 2024	Jan. 31, 2024
Current assets:
Cash and cash equivalents	$ 27,158	$ 72,099
Prepaid expenses and other current assets	21,188	14,356
Total current assets	48,346	86,455
Noncurrent assets:
Property and equipment, net	12,792	17,644
Deferred financing costs	20,000
Total noncurrent assets	32,792	17,644
Total assets	81,138	104,099
Current:
Accounts payable and accrued liabilities	238,151	165,212
Convertible promissory note, net of unamortized debt discount of $39,917 and $0	200,983	95,000
Derivative liability	637,477	2,547,458
Total current liabilities	2,014,848	3,134,498
Long-term:
Long-term debt - SBA, net of current portion	32,400	32,400
Total long-term liabilities	32,400	32,400
Total liabilities	2,047,248	3,166,898
Commitments and Contingencies
Stockholders’ deficit:
Class A common stock - $.00001 par value; 500,000 authorized; 500,000 shares issued and outstanding	5	5
Common stock - $.00001 par value; 149,500,000 authorized; 51,156,228 and 49,813,861 shares issued and outstanding, respectively	512	498
Additional paid-in capital	57,230,440	58,538,033
Subscription receivable	(101,100)	(117,850)
Accumulated deficit	(59,095,967)	(61,483,485)
Total stockholders’ deficit	(1,966,110)	(3,062,799)
Total liabilities and stockholders’ deficit	81,138	104,099
Related Party [Member]
Current:
Accrued expenses, related party	8,117
Advances, related party	185,000
Notes payable	736,598	326,828
Nonrelated Party [Member]
Current:
Notes payable	$ 8,522

v3.24.4

Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($)	Oct. 31, 2024	Jan. 31, 2024
Convertible promissory note, unamortized debt discount	$ 39,917	$ 0
Common stock, par value	$ 0.00001	$ 0.00001
Common stock, shares authorized	149,500,000	149,500,000
Common stock, shares issued	51,156,228	49,813,861
Common stock, shares outstanding	51,156,228	49,813,861
Common Class A [Member]
Common stock, par value	$ 0.00001	$ 0.00001
Common stock, shares authorized	500,000	500,000
Common stock, shares issued	500,000	500,000
Common stock, shares outstanding	500,000	500,000

v3.24.4

Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Income Statement [Abstract]
Revenues
Expenses:
Geological and geophysical costs	42,300	112,104	409,987	125,792
Salaries and benefits	56,806	55,737	176,805	152,419
Professional services	46,691	33,904	189,092	121,437
General and administrative	133,693	49,422	441,751	127,851
Net operating expenses	279,490	251,167	1,217,635	527,499
Loss from operations	(279,490)	(251,167)	(1,217,635)	(527,499)
Other income (expense):
Interest expense	(83,932)	(88,680)	(180,785)	(209,984)
Other income	956	1,126	2,882	2,365
Gain on change in fair value of derivative liability	1,289,458	86,112	3,783,056	160,551
Total other income (expense)	1,206,482	(1,442)	3,605,153	(47,068)
Net income (loss)	$ 926,992	$ (252,609)	$ 2,387,518	$ (574,567)
Net income (loss) per share of common stock – basic	$ 0.02	$ (0.01)	$ 0.05	$ (0.02)
Net income (loss) per share of common stock - diluted	$ 0.02	$ (0.01)	$ 0.04	$ (0.02)
Weighted average shares outstanding - basic	50,794,090	32,289,211	50,193,594	24,676,301
Weighted average shares outstanding - diluted	61,601,303	32,289,211	62,349,267	24,676,301

v3.24.4

Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) - USD ($)	Common Stock [Member] Common Class A [Member]	Common Stock [Member]	Subscription Receivable [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance at Jan. 31, 2023	$ 1	$ 186	$ (117,468)	$ 56,941,222	$ (57,403,227)	$ (579,286)
Balance, shares at Jan. 31, 2023	102,000	18,671,159
Cashless exercise of options		$ 3	(16,750)	16,747
Cashless exercise of options, shares		250,000
Stock based compensation				19,265		19,265
Net income ( loss)					(118,579)	(118,579)
Shares issued for conversion of notes		$ 13		70,930		70,943
Shares issued for conversion of notes, shares		1,251,270
Resolution of derivative liabilities due to debt conversions and untainted warrants				43,931		43,931
Receipt of subscription receivable			16,368			16,368
Balance at Apr. 30, 2023	$ 1	$ 202	(117,850)	57,092,095	(57,521,806)	(547,358)
Balance, shares at Apr. 30, 2023	102,000	20,172,429
Balance at Jan. 31, 2023	$ 1	$ 186	(117,468)	56,941,222	(57,403,227)	(579,286)
Balance, shares at Jan. 31, 2023	102,000	18,671,159
Net income ( loss)						(574,567)
Balance at Oct. 31, 2023	$ 3	$ 498	(117,850)	58,423,801	(57,977,794)	328,658
Balance, shares at Oct. 31, 2023	250,000	49,813,861
Balance at Apr. 30, 2023	$ 1	$ 202	(117,850)	57,092,095	(57,521,806)	(547,358)
Balance, shares at Apr. 30, 2023	102,000	20,172,429
Stock based compensation		$ 10		24,354		24,364
Net income ( loss)					(203,379)	(203,379)
Shares issued for conversion of notes		$ 17		61,078		61,095
Shares issued for conversion of notes, shares		1,690,073
Resolution of derivative liabilities due to debt conversions and untainted warrants				125,520		125,520
Stock based compensation, shares		978,300
Issuance of common stock and warrants in private placement		$ 35		159,965		160,000
Issuance of common stock and warrants in private placement, shares		3,542,778
Balance at Jul. 31, 2023	$ 1	$ 264	(117,850)	57,463,012	(57,725,185)	(379,758)
Balance, shares at Jul. 31, 2023	102,000	26,383,580
Stock based compensation				19,614		19,614
Net income ( loss)					(252,609)	(252,609)
Shares issued for conversion of notes		$ 27		101,215		101,242
Shares issued for conversion of notes, shares		2,725,574
Resolution of derivative liabilities due to debt conversions and untainted warrants				(11,241)		(11,241)
Issuance of common stock and warrants in private placement	$ 4	$ 205		851,201		851,410
Issuance of common stock and warrants in private placement, shares	398,000	20,454,707
Shares exchanged	$ (2)	$ 2
Shares exchanged, shares	(250,000)	250,000
Balance at Oct. 31, 2023	$ 3	$ 498	(117,850)	58,423,801	(57,977,794)	328,658
Balance, shares at Oct. 31, 2023	250,000	49,813,861
Balance at Jan. 31, 2024	$ 5	$ 498	(117,850)	58,538,033	(61,483,485)	(3,062,799)
Balance, shares at Jan. 31, 2024	500,000	49,813,861
Cashless exercise of options		$ 1		(1)
Cashless exercise of options, shares		70,002
Stock based compensation				77,626		77,626
Settlement of subscription receivable			16,750			16,750
Net income ( loss)					311,381	311,381
Balance at Apr. 30, 2024	$ 5	$ 499	(101,100)	58,615,658	(61,172,104)	(2,657,042)
Balance, shares at Apr. 30, 2024	500,000	49,883,863
Balance at Jan. 31, 2024	$ 5	$ 498	(117,850)	58,538,033	(61,483,485)	$ (3,062,799)
Balance, shares at Jan. 31, 2024	500,000	49,813,861
Cashless exercise of options, shares						75,000
Net income ( loss)						$ 2,387,518
Shares issued for conversion of notes, shares		867,389
Balance at Oct. 31, 2024	$ 5	$ 512	(101,100)	57,230,440	(59,095,967)	(1,966,110)
Balance, shares at Oct. 31, 2024	500,000	51,156,228
Balance at Apr. 30, 2024	$ 5	$ 499	(101,100)	58,615,658	(61,172,104)	(2,657,042)
Balance, shares at Apr. 30, 2024	500,000	49,883,863
Stock based compensation				173,569		173,569
Net income ( loss)					1,149,145	1,149,145
Shares issued for conversion of notes		$ 2		34,998		35,000
Shares issued for conversion of notes, shares		185,381
Resolution of derivative liabilities due to debt conversions and untainted warrants				17,739		17,739
Reclass of APIC to derivative liabilities for tainted warrants				(3,331,913)		(3,331,913)
Balance at Jul. 31, 2024	$ 5	$ 501	(101,100)	55,510,051	(60,022,959)	(4,613,502)
Balance, shares at Jul. 31, 2024	500,000	50,069,244
Stock based compensation		$ 2		106,133		106,135
Net income ( loss)					926,992	926,992
Shares issued for conversion of notes		$ 7		79,393		79,400
Shares issued for conversion of notes, shares		682,008
Resolution of derivative liabilities due to debt conversions and untainted warrants				34,737		34,737
Reclass of APIC to derivative liabilities for tainted warrants				1,473,714		1,473,714
Shares issued for cash, net		$ 1		6,413		6,414
Shares issued for cash, net, shares		79,976
Shares issued for deferred financing costs		$ 1		19,999		20,000
Shares issued for deferred financing costs, shares		100,000
Stock based compensation, shares		225,000
Balance at Oct. 31, 2024	$ 5	$ 512	$ (101,100)	$ 57,230,440	$ (59,095,967)	$ (1,966,110)
Balance, shares at Oct. 31, 2024	500,000	51,156,228

v3.24.4

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
Cash flows from operating activities:
Net income (loss)	$ 2,387,518	$ (574,567)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation	4,852	4,534
Stock based compensation	357,330	63,243
Amortization of debt discounts	112,835	197,477
Gain on change in fair value of derivative liabilities	(3,783,056)	(160,551)
Changes in assets and liabilities:
Prepaid expenses	17,438	8,544
Accounts payable and accrued expenses	77,339	37,017
Accrued expenses to related party	8,117
Cash flows used in operating activities:	(817,627)	(424,303)
Cash flows from financing activities:
Proceeds from advances, related party	210,000	1,363
Repayments of advances, related party	(25,000)
Proceeds from notes payable, related party	467,000	35,000
Repayment on notes payable, related party	(40,000)
Repayments on notes payable	(16,228)	(19,058)
Proceeds from convertible promissory notes	286,000	80,000
Repayments on convertible promissory notes	(115,500)
Proceeds from the issuance of common stock for cash, net	6,414
Proceeds from the issuance of common stock and warrants in a private placement		999,751
Receipt of subscription receivable		16,368
Net cash provided by financing activities	772,686	1,113,424
Increase (decrease) in cash and cash equivalents	(44,941)	689,121
Cash and cash equivalents, beginning of period	72,099	32,616
Cash and cash equivalents, end of period	27,158	721,737
Supplemental disclosure of cash flow information:
Income tax paid
Interest paid	948
Supplemental disclosure of non-cash items:
Resolution of derivative liabilities due to debt conversions and untainted warrants	52,476	156,309
Reclass of APIC to derivative liabilities for tainted warrants	1,858,199	1,901
Debt discounts due to derivative liabilities	67,352	146,368
Shares issued for conversion of debt and interest	114,400	233,280
Expenses paid by related party on behalf of the Company		21,828
Prepaid insurance financed with note payable	24,750	24,850
Cashless exercise of warrants		16,750
Settlement of subscription and interest receivable	17,230
Non-cash equipment addition		1,908
Non-cash payment on note payable, related party		9,751
Shares issued for deferred financing costs	$ 20,000

v3.24.4

Pay vs Performance Disclosure - USD ($)	3 Months Ended						9 Months Ended
	Oct. 31, 2024	Jul. 31, 2024	Apr. 30, 2024	Oct. 31, 2023	Jul. 31, 2023	Apr. 30, 2023	Oct. 31, 2024	Oct. 31, 2023
Pay vs Performance Disclosure [Table]
Net Income (Loss)	$ 926,992	$ 1,149,145	$ 311,381	$ (252,609)	$ (203,379)	$ (118,579)	$ 2,387,518	$ (574,567)

v3.24.4

Insider Trading Arrangements	3 Months Ended
	Oct. 31, 2024
Insider Trading Arrangements [Line Items]
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

v3.24.4

Basis of Presentation	9 Months Ended
	Oct. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	NOTE 1 – Basis of Presentation   The consolidated financial statements included herein have been prepared by Liberty Star Uranium & Metals Corp. (the “Company”, “we”, “our”) without audit, pursuant to the rules and regulations of the United States Securities and Exchange Commission (“SEC”) and should be read in conjunction with our annual report on Form 10-K for the year ended January 31, 2024 as filed with the SEC on May 15, 2024. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) have been omitted, as permitted by the SEC, although we believe the disclosures which are made are adequate to make the information presented not misleading. The consolidated financial statements reflect, in the opinion of management, all normal recurring adjustments necessary to present fairly our financial position at October 31, 2024, and the results of our operations and cash flows for the periods presented.   Interim results are subject to significant seasonal variations and the results of operations for the three and nine months ended October 31, 2024, are not necessarily indicative of the results to be expected for the full year.

v3.24.4

Going Concern	9 Months Ended
	Oct. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Going Concern	NOTE 2 – Going Concern   The Company has a history of and expects to continue to report stockholders’ deficit, negative cash flows from operations and loss from operations. Additional funds are required for further exploratory activity and to maintain its claims prior to attaining a revenue generating status. There are no assurances that a commercially viable mineral deposit exists on any of our properties. In addition, the Company may not find sufficient ore reserves to be commercially mined. As such, there is substantial doubt about the Company’s ability to continue as a going concern.   Management is working to secure additional funds through the exercise of stock warrants already outstanding, equity financing, debt financing or joint venture agreements. The consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties.

v3.24.4

Summary of Significant Accounting Policies	9 Months Ended
	Oct. 31, 2024
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	NOTE 3 – Summary of Significant Accounting Policies   Fair Value   Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) ASC 820 Fair Value Measurements and Disclosures (“ASC 820”), defines fair value, establishes a framework for measuring fair value and enhances disclosures about fair value measurements. It defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value:   Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities.   Level 2: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities that are not active; and model-driven valuations whose inputs are observable or whose significant value drivers are observable. Valuations may be obtained from, or corroborated by, third-party pricing services.   Level 3: Unobservable inputs to measure fair value of assets and liabilities for which there is little, if any market activity at the measurement date, using reasonable inputs and assumptions based upon the best information at the time, to the extent that inputs are available without undue cost and effort.    Schedule of Fair Value of Financial Instruments               Fair value measurements at reporting date using:   Description     Fair Value       Quoted prices in active markets for identical liabilities (Level 1)       Significant other observable inputs (Level 2)       Significant unobservable inputs (Level 3)   Warrant and convertible note derivative liabilities at October 31, 2024   $ 637,477       –       –     $ 637,477   Warrant and convertible note derivative liabilities at January 31, 2024   $ 2,547,458       –       –     $ 2,547,458     Our financial instruments consist of cash and cash equivalents, prepaid expenses, accounts payable, accrued liabilities, notes payable, convertible notes payable, and derivative liabilities. It is management’s opinion that we are not exposed to significant interest, currency or credit risks arising from these financial instruments. With the exception of the derivative liabilities, the fair value of these financial instruments approximates their carrying values based on their short maturities or for long-term debt based on borrowing rates currently available to us for loans with similar terms and maturities. Gains and losses recognized on changes in estimated fair value of the derivative liabilities are reported in other income (expense) as gain (loss) on change in fair value of derivative liabilities.   Net income (loss) per share   Basic net income (loss) per common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding during the period. Potential common stock equivalents are determined using the treasury stock method. For diluted net income (loss) per share purposes, the Company excludes stock options and other stock-based awards, including shares issued as a result of option exercises that are subject to repurchase by the Company, whose effect would be anti-dilutive from the calculation.   During the three and nine months ended October 31, 2024, the impact of 1,525,386 and 1,743,667 of stock options and 9,281,827 and 10,412,006 of warrants and 0 shares issuable from convertible notes, respectively, were considered for their dilutive effects. During the three and nine months ended October 31, 2023, the impact of 0 of stock options, 2,099,941 and 3,450,319 of warrants, respectively, were excluded from the calculation as their impact would be anti-dilutive.   A reconciliation of the weighted average shares outstanding used in basic and diluted earnings per share computation is as follows:  Schedule of Reconciliation of Weighted Average Shares Outstanding     2024     2023     2024     2023       For the Three Months Ended     For the Nine Months Ended       October 31,     October 31,       2024     2023     2024     2023   Basic income (loss) per common share                                 Net income (loss) available to common shareholders   $ 926,992     $ (252,609 )   $ 2,387,518     $ (574,567 ) Derivative (gain) loss associated with convertible debt     (11,432 )     -       (14,876 )     -   Interest expense associated with convertible debt     (5,142 )     -       (16,415 )     -   Net income (loss) for dilutive calculation   $ 910,418     $ (252,609 )   $ 2,356,227     $ (574,567 )                                   Weighted average common shares outstanding     50,794,090       32,289,211       50,193,594       24,676,301   Dilutive effect of convertible debt     -       -       -       -   Dilutive effect of common stock warrants     9,281,827       -       10,412,006       -   Dilutive effect of common stock options     1,525,386       -       1,743,667       -   Weighted average shares outstanding for diluted net income (loss) per share     61,601,303       32,289,211       62,349,267       24,676,301

v3.24.4

Related Party Transactions	9 Months Ended
	Oct. 31, 2024
Related Party Transactions [Abstract]
Related Party Transactions	NOTE 4 – Related Party Transactions   Our CEO, Brett Gross, was elected as President and Chief Executive Officer on December 7, 2018. On September 29, 2023, Mr. Gross resigned from his position as President and Chief Executive Officer of the Company. Patricia Madaris, VP Finance and Chief Financial Officer will serve as the Interim Chief Executive Officer.   Accrued Expenses   As of October 31, 2024, and January 31, 2024, we had a balance of accrued unpaid vacation days of $8,117 and $0, respectively, to Patricia Madaris, VP Finance & CFO.   Advances   During the nine months ended October 31, 2024, the Company received advances of $210,000 from Pete O’Heeron, Chairman of the Board, and repaid $25,000 of advances. The advances are unsecured, non-interest bearing and is payable on demand. As of October 31, 2024, the advances related party balance was $185,000.   Note payable   On January 31, 2023, the Company entered into a promissory note with Brett Gross for $50,000 and received cash proceeds. During the year ended January 31, 2024, the Company signed an addendum to the January 31, 2023 promissory note to increase the promissory note with Mr. Gross to $86,579. The note bears interest at 10% and matures on January 31, 2024. On February 12, 2024, the Company signed an addendum to the January 31, 2023 promissory note to net the $16,750 recourse loan with Mr. Gross and accrued interest of $480 with the promissory note. During the nine months ended October 31, 2024, the Company repaid Mr. Gross $40,000. As of October 31, 2024 and January 31, 2024, the note payable related party balance was $19,598 and $76,828, respectively.   On January 25, 2024, the Company entered into a promissory note with Pete O’Heeron, Chairman of the Board, for $250,000 and received cash proceeds. The note bears interest at 10% and matures on January 25, 2025.   On February 13, 2024, the Company entered into a promissory note with Pete O’Heeron, Chairman of the Board, in the aggregate principal amount of $210,000. The note bears interest at 10% matures on February 13, 2025.   On April 3, 2024, the Company entered into a promissory note with Pete O’Heeron, Chairman of the Board, in the aggregate principal amount of $75,000. The note bears interest at 10% matures on April 3, 2025.   On May 1, 2024, the Company entered into a promissory note with Pete O’Heeron, Chairman of the Board, in the aggregate principal amount of $45,000. The note bears interest at 10% matures on May 1, 2025.   On May 20, 2024, the Company entered into a promissory note with Pete O’Heeron, Chairman of the Board, in the aggregate principal amount of $67,000. The note bears interest at 10% matures on May 20, 2025.   On July 5, 2024, the Company entered into a promissory note with Pete O’Heeron, Chairman of the Board, in the aggregate principal amount of $70,000. The note bears interest at 10% matures on July 5, 2025.   As of October 31, 2024, and January 31, 2024, the note payable related party balance was $736,598 and $326,828, respectively.   Other   On February 21, 2024, the Company received a notice to exercise 75,000 options to purchase shares of common stock on a cashless basis resulting in the issuance of a net of 70,002 shares of common stock.   On June 28, 2024, the Company granted 337,501 options to an officer and a member of the board of directors. The options expire ten years following issuance and have an exercise price of $0.226. The options vest upon issuance and have a total fair value of $76,275. The Company valued the options using the Black-Scholes model with the following key assumptions: fair value stock price, $0.226, Exercise price, $0.226, Term 10 years, Volatility 178%, and Discount rate 4.36% and a dividend yield of 0%.

v3.24.4

Stockholders’ deficit	9 Months Ended
	Oct. 31, 2024
Share-Based Payment Arrangement [Abstract]
Stockholders’ deficit	NOTE 5 – Stockholders’ deficit   Common Stock   Our common shares are all of the same class, are voting and entitle stockholders to receive dividends to the extent declared by the Board of Directors. Upon liquidation or wind-up, stockholders are entitled to participate equally with respect to any distribution of net assets.   On July 3, 2024, the Board of Directors amended the articles of incorporation to increase the Company’s common stock by 75,000,000 shares.   Common Stock for Services   On May 26, 2023, the Company entered into a twelve-month stock compensation and subscription agreement with an investor relations firm that includes the issuance of 978,300 shares of restricted common stock. Upon signing the agreement, the Company issued 978,300 shares of restricted common stock and will recognize the expense over the twelve-month service period. The shares of restricted common stock will be subject to a six-month hold period from the date of issuance. During the nine months ended October 31, 2024, the Company recognized $12,229 of expense related to this agreement.   On August 5, 2024, the Company entered into a twelve-month stock compensation and subscription agreement with an investor relations firm that includes the issuance of 225,000 shares of restricted common stock with a fair value of $45,000. During the nine months ended October 31, 2024, the Company recognized $45,000 of expense related to this agreement.   Equity Financing   On September 25, 2024, the Company entered into an investment agreement (the “Investment Agreement”) with GHS Investments, LLC (the “Investor”), whereby the Investor has agreed to invest up to $10,000,000 to purchase shares of our common stock over a 24-month-term that commenced on September 25, 2024. Subject to the terms and conditions of the Investment Agreement and Registration Agreement, we may, in our sole discretion, deliver a put notice to the Investor which states the dollar amount which we intend to sell to the Investor on a certain date. The amount that we shall be entitled to sell to Investor shall be equal to two hundred percent (200%) of the average daily volume (U.S. market only) of the common stock for the ten (10) trading days prior to the applicable notice date so long as such amount does not exceed a calculated dollar amount per every 10 days of $500,000. The minimum amount shall be equal to $10,000. On October 24, 2024, the Investor purchased 79,976 restricted shares of the Company’s common stock for net proceeds of $6,414 ($0.08 per share), after deducting the legal fees and clearing expenses. As consideration for entering into the purchase agreement, the Company issued 100,000 shares of common stock to the Investor as a commitment fee. The shares were valued at approximately $20,000 and were recorded as deferred offering costs on the balance sheet. The deferred charges will be charged against paid-in capital upon future proceeds from the sale of common stock under this agreement. During the nine months ended October 31, 2024, $1,000 of deferred offering cost was charged against paid-in capital. As of October 31, 2024, unamortized deferred offering costs totaled $20,000.   Shares Issued for Conversion of Notes   During the nine months ended October 31, 2024, the Company issued a total of 867,389 shares of our common stock for conversions of $110,000 in principal and $4,000 of interest on convertible notes payable at an exercise price ranging from $0.0961 to $0.1888. The conversion was in accordance with the terms of the agreement and no gain or loss was recognized.   Subscription Receivable   On September 29, 2022, the Company granted 674,000 options to purchase shares of common stock to employees. The options expire ten years following issuance and have an exercise price of $0.15. The options vested upon issuance and have a total fair value of $104,226. On the same day, the Company issued note agreements to the employees totaling $101,100 and the employees exercised the 674,000 options. The notes bear interest of 3.15% per annum, are due on September 30, 2027, and were recorded as a subscription receivable.     On March 13, 2023, the Company granted 250,000 options to purchase shares of common stock to the Brett Gross, the Company’s prior CEO. The options expire ten years following issuance and have an exercise price of $0.067. The options vested upon issuance and have a total fair value of $16,750. On the same day, the Company issued a note agreement to the Mr. Gross totaling $16,750 and Mr. Gross exercised the 250,000 options. The note bears interest of 3.15% per annum, is due on March 15, 2028, and was recorded as a subscription receivable. On February 12, 2024, the Company signed an addendum to the January 31, 2023, promissory note to net the $16,750 subscription receivable with Mr. Gross and accrued interest of $480 with the promissory note.   As of October 31, 2024, and January 31, 2024, the subscription receivable was $101,100 and $117,850, respectively.   Stock Options   Qualified and non-qualified incentive stock options outstanding at October 31, 2024 are as follows:  Schedule of Stock Option Activity     Number of options     Weighted average exercise price per share   Outstanding, January 31, 2024     2,808,760     $ 0.83   Granted     632,238       0.22   Expired     –       –   Exercised     (75,000 )     0.05   Outstanding, October 31, 2024     3,365,998     $ 0.74                     Exercisable, October 31, 2024     3,203,498     $ 0.76     These options had a weighted average remaining life of 9.11 years and have an aggregate intrinsic value of $253,984 as of October 31, 2024. The aggregate intrinsic value is calculated based on the stock price of $0.178 per share as of October 31, 2024.   On December 4, 2023, the Company entered into a letter of understanding with a geologist for services to be provided to the Company. As compensation, the Company will pay $4,000 per month and grant the geologist 10,000 options to purchase shares of common stock upon signing the agreement and monthly stock options to purchase 4,000 shares of common stock on a month-to-month basis. The options have a strike price equal to the closing price per share on the day the options are issued, vest upon issuance and expire in three years. During the nine months ended October 31, 2024, the Company granted 54,000 options to purchase shares of common stock to geologist. The exercise price of the options ranges from $0.047 to $0.725. The total fair value of these option grants at issuance was $15,024. During the nine months ended October 31, 2024, the Company recognized $15,024 of expense related to these options.   On June 28, 2024, the Company granted 165,737 options to an employee. The options expire ten years following issuance and have an exercise price of $0.226. The options vest upon issuance and have a total fair value of $37,457. The Company valued the options using the Black-Scholes model with the following key assumptions: fair value stock price, $0.226, Exercise price, $0.226, Term 10 years, Volatility 178%, and Discount rate 4.36% and a dividend yield of 0%.   On August 23, 2024, the Company granted 75,000 options to a board member. The options expire ten years following issuance and have an exercise price of $0.16. The options vest upon issuance and have a total fair value of $12,337. The Company valued the options using the Black-Scholes model with the following key assumptions: fair value stock price, $0.226, Exercise price, $0.226, Term 6.3 years, Volatility 191%, and Discount rate 3.71% and a dividend yield of 0%.   During the nine months ended October 31, 2024 and 2023, we recognized $300,101 and $38,553 of compensation expense related to incentive and non-qualified stock options previously granted to officers, employees and consultants.   As of October 31, 2024, there was $47,901 of unrecognized share-based compensation for all share-based awards outstanding.     Warrants   As of October 31, 2024, there were 14,032,073 warrants to purchase shares of common stock outstanding and 13,524,541 warrants to purchase shares of common stock exercisable. The warrants have a weighted average remaining life of 1.75 years and a weighted average exercise price of $0.12 per warrant for one common share. The warrants had an aggregate intrinsic value of $1,618,975 as of October 31, 2024.   Stock warrants outstanding at October 31, 2024 are as follows:  Schedule of Stock Warrants Outstanding     Number of warrants     Weighted average exercise price per share   Outstanding, January 31, 2024     14,254,813     $ 0.21   Issued     –       –   Expired     (222,740 )     1.26   Exercised     –       –   Outstanding, October 31, 2024     14,032,073     $ 0.19                     Exercisable, October 31, 2024     13,524,541     $ 0.12

v3.24.4

Derivative Liabilities	9 Months Ended
	Oct. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Liabilities	NOTE 6 – Derivative Liabilities   The embedded conversion feature in the convertible debt instruments that the Company issued (See Note 8), that became convertible during the nine months ended October 31, 2024, qualified it as a derivative instrument since the number of shares issuable under the note is indeterminate based on guidance in FASB ASC 815, Derivatives and Hedging. These convertible notes tainted all other equity linked instruments including outstanding warrants and fixed rate convertible debt on the date that the instrument became convertible.   The valuation of the derivative liabilities of the warrants was determined through the use of a Monte Carlo option pricing model that values the liability of the warrants based on a risk-neutral valuation where the price of the warrant is its discounted expected value. The technique applied generates a large number of possible (but random) price paths for the underlying common stock via simulation, and then calculates the associated exercise value (i.e. “payoff”) of the warrant for each path. These payoffs are then averaged and discounted to a current valuation date resulting in the fair value of the warrant.   The valuation of the derivative liabilities attached to the convertible debt was arrived at through the use of a Monte Carlo model that values the derivative liability within the notes. The technique applied generates a large number of possible (but random) price paths for the underlying (or underlyings) via simulation, and then calculates the associated payment value (cash, stock, or warrants) of the derivative features. The price of the underlying common stock is modeled such that it follows a geometric Brownian motion with constant drift, and elastic volatility (increasing as stock price decreases). The stock price is determined by a random sampling from a normal distribution. Since the underlying random process is the same, for enough price paths, the value of the derivative is derived from path dependent scenarios and outcomes. The features in the notes that were analyzed and incorporated into the model included the conversion features with the reset provisions, the call/redemption/prepayment options, and the default provisions. Based on these features, there are six primary events that can occur; payments are made in cash; payments are made with stock; the note holder converts upon receiving a redemption notice; the note holder converts the note; the issuer redeems the note; or the Company defaults on the note. The model simulates the underlying economic factors that influenced which of these events would occur, when they were likely to occur, and the specific terms that would be in effect at the time (i.e. stock price, conversion price, etc.). Probabilities were assigned to each variable such as redemption likelihood, default likelihood, and timing and pricing of reset events over the remaining term of the notes based on management projections. This led to a cash flow simulation over the life of the note. A discounted cash flow for each simulation was completed, and it was compared to the discounted cash flow of the note without the embedded features, thus determining a value for the derivative liabilities.     Key inputs and assumptions used to value the convertible note when it became convertible and upon settlement, and warrants upon tainting, were as follows:     ● The stock projections are based on the historical volatilities for each date. The volatility of 188.8% is based on historical prices over a lookback period equivalent to the expected term of 1.8 years. The stock price projection was modeled such that it follows a geometric Brownian motion with constant drift and constant volatility, starting with the recast stock price at each valuation date;         ● The Holder will exercise the warrant at maturity if the stock price was above the exercise price;         ● Discount rate was based on risk free rates of 4.36% in effect based on the remaining term and date of each valuation and instrument;         ● Dividend yield: 0%;         ● Exercise Price: $0.04 to $16.20. $20M/number shares issued and outstanding at maturity (exercise date);         ● Number of Options: $1M/exercise price; and         ● The shares issued and outstanding is based on the initial 10,888,894 shares as of 10/31/21 to 51,156,228 shares as of 10/31/24 and a 2.49% growth (a lower growth from last quarter) monthly at 10/31/24 and future financing events raising $500,000 annually through the sale of common stock at a 25% discount.   Using the results from the model, the Company recorded a derivative liability during the nine months ended October 31, 2024 of $67,352 for the fair value of the convertible feature included in the Company’s convertible debt instruments. The derivative liability recorded for the convertible feature created a “day 1” derivative loss of $0 and a debt discount of $67,352 that is being amortized over the remaining term of the note using the effective interest rate method. Interest expense related to the amortization of this debt discount for the nine months ended October 31, 2024, was $67,352. The remaining unamortized debt discount related to the derivative liability was $0 as of October 31, 2024.   During the nine months ended October 31, 2024, the Company recorded a gain of $3,783,056 due to a change in the fair value of the derivative liabilities to reflect the value of the derivative liabilities for warrants as of October 31, 2024.   Using the results from the model, the Company recorded a derivative liability during the nine months ended October 31, 2023 of $146,368 for the fair value of the convertible feature included in the Company’s convertible debt instruments. The derivative liability recorded for the convertible feature created a “day 1” derivative loss of $0 and a debt discount of $146,368 that is being amortized over the remaining term of the note using the effective interest rate method. Interest expense related to the amortization of this debt discount for the nine months ended October 31, 2023, was $197,477. The remaining unamortized debt discount related to the derivative liability was $0 as of October 31, 2023.   During the nine months ended October 31, 2023, the Company recorded $156,309 due to the conversions of a portion of the Company’s convertible notes. The Company also recorded a change in the fair value of the derivative liabilities as a gain of $160,551 to reflect the value of the derivative liabilities for warrants and convertible notes as of October 31, 2023.   The following table sets forth a reconciliation of changes in the fair value of the Company’s derivative liabilities:  Schedule of Changes in Fair value of Derivative Liabilities     Nine months ended October 31,       2024     2023   Beginning balance   $ 2,547,458     $ 172,393   Total gain     (3,783,056 )     (160,551 ) Settlements     (52,476 )     (156,309 ) Additions recognized as debt discount     67,352       146,368   Changes due to tainted (untainted) warrants     1,858,199       (1,901 ) Ending balance   $ 637,477     $ -                     Change in fair value of derivative liabilities included in earnings relating to derivatives   $ (3,783,056 )   $ (160,551 )

v3.24.4

Long-term debt and convertible promissory notes	9 Months Ended
	Oct. 31, 2024
Debt Disclosure [Abstract]
Long-term debt and convertible promissory notes	NOTE 7 – Long-term debt and convertible promissory notes   Following is a summary of convertible promissory notes:  Schedule of Convertible Promissory Notes     October 31, 2024     January 31, 2024                 8% convertible note payable issued January 2024, due October 2024   $ -     $ 110,000   10% convertible note payable issued February 2024, due November 2024     10,500       –   10% convertible note payable issued June 2024, due March 2025     66,000       –   10% convertible note payable issued August 2024, due May 2025     67,200       –   10% convertible note payable issued October 2024, due July 2025     97,200       –   Convertible note payable     240,900       110,000   Less debt discount     (39,917 )     (15,000 ) Less current portion of convertible notes     (200,983 )     (95,000 ) Long-term convertible notes payable   $ –     $ –     On January 12, 2024, the Company entered into a convertible promissory note with 1800 Diagonal Lending in the aggregate principal amount of $110,000 (the “January 2024 Note”). The note bears interest at 8%, with an Original Issue Discount of $10,000 plus an additional $5,000 to pay for transaction fees of the lender, matures on March 24,2024, and is convertible after 180 days into shares of the Company’s common stock at a price of 75% of the average of the lowest 5 weighted average market prices of the Company’s common stock during the 10 trading days prior to conversion. During the nine months ended October 31, 2024, the noteholder converted a total of $110,000 of the note for 867,389 shares of the Company’s common stock.   As of October 31, 2024, the note balance was $0. As of January 31, 2024, the note balance was $95,000, net of $15,000 discount.   On February 23, 2024, the Company entered into a promissory note with 1800 Diagonal Lending in the aggregate principal amount of $126,000 (the “February 2024 Note”). The note bears interest at 10%, with an Original Issue Discount of $21,000 plus an additional $5,000 to pay for transaction fees of the lender, matures on November 30, 2024. Pursuant to the terms of the Note, the outstanding principal and accrued interest on the Note shall be paid in 4 set monthly cash payments beginning six months from the effective date. The note may be prepaid with no penalty. The note allows an event of default which may be convertible into shares of the Company’s common stock as set forth therein. At any time following an event of default, the note is convertible into shares of the Company’s common stock at a price of 65% of the lowest weighted average market price of the Company’s common stock during the 10 trading days prior to conversion. During the nine months ended October 31, 2024, the Company repaid $115,500 of principal on the note. As of October 31, 2024, the note balance was $7,724, net of $2,776 discount.   On June 13, 2024, the Company entered into a promissory note with 1800 Diagonal Lending in the aggregate principal amount of $126,000 (the “June 2024 Note”). The note bears interest at 10%, with an Original Issue Discount of $21,000 plus an additional $5,000 to pay for transaction fees of the lender, matures on March 15, 2025. Pursuant to the terms of the Note, the outstanding principal and accrued interest on the Note shall be paid in 4 set monthly cash payments beginning six months from the effective date. The note may be prepaid with no penalty. The note allows an event of default which may be convertible into shares of the Company’s common stock as set forth therein. At any time following an event of default, the note is convertible into shares of the Company’s common stock at a price of 65% of the lowest weighted average market price of the Company’s common stock during the 10 trading days prior to conversion. As of October 31, 2024, note balance was $63,545, net of $2,455 discount.   On August 28, 2024, the Company entered into a promissory note with 1800 Diagonal Lending in the aggregate principal amount of $67,200 (the “August 2024 Note”). The note bears interest at 10%, with an Original Issue Discount of $11,200 plus an additional $6,000 to pay for transaction fees of the lender, matures on May 30, 2025. Pursuant to the terms of the Note, the outstanding principal and accrued interest on the Note shall be paid in 4 set monthly cash payments beginning six months from the effective date. The note may be prepaid with no penalty. The note allows an event of default which may be convertible into shares of the Company’s common stock as set forth therein. At any time following an event of default, the note is convertible into shares of the Company’s common stock at a price of 65% of the lowest weighted average market price of the Company’s common stock during the 10 trading days prior to conversion. As of October 31, 2024, note balance was $54,003, net of $13,197 discount.     On October 22, 2024, the Company entered into a promissory note with 1800 Diagonal Lending in the aggregate principal amount of $97,200 (the “October 2024 Note”). The note bears interest at 10%, with an Original Issue Discount of $16,200 plus an additional $6,000 to pay for transaction fees of the lender, matures on July 30, 2025. Pursuant to the terms of the Note, the outstanding principal and accrued interest on the Note shall be paid in 4 set monthly cash payments beginning six months from the effective date. The note may be prepaid with no penalty. The note allows an event of default which may be convertible into shares of the Company’s common stock as set forth therein. At any time following an event of default, the note is convertible into shares of the Company’s common stock at a price of 65% of the lowest weighted average market price of the Company’s common stock during the 10 trading days prior to conversion. As of October 31, 2024, note balance was $75,711, net of $21,489 discount.   During the nine months ended October 31, 2024 and 2023, the Company recorded debt discounts of $67,352 and $146,368, respectively, due to the derivative liabilities, and original issue debt discounts and fees paid to lender of $70,400 and $17,350, respectively, due to the convertible notes. The Company recorded amortization of these discounts of $112,835 and $197,477 for the nine months ended October 31, 2024 and 2023, respectively.   Notes Payable   On June 22, 2020, the Company received loan proceeds of $32,300 (net of a $100 loan fee) under the SBA’s Economic Injury Disaster Loan program (“EIDL”). The EIDL loan, dated June 16, 2020, bears interest at 3.75%, has a 30-year term, and is due in monthly installments of $158 beginning June 18, 2021 (extended to December 18, 2022).   In April 2024, the Company entered into a Premium Finance Agreement related to an insurance policy. The policy premiums total $33,500 for a one-year policy period. The Company financed $24,750 of the policy over a nine-month period. The monthly payments under the agreement are due in nine installments of $2,903, at an annual interest rate of 13.2%.   As of October 31, 2024, the notes payable, net balance was $40,922, which include term long notes payable of $32,400 and current portion of notes payable of $8,522, with accrued interest of $2,729. As of January 31, 2024, the note principal balance totaled $32,400, with accrued interest of $2,729, and is included in long-term debt.

v3.24.4

Commitments and contingencies	9 Months Ended
	Oct. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and contingencies	NOTE 8 – Commitments and contingencies   We currently rent storage space for $105 per month in Tombstone, Arizona on a month-to-month basis.   We are required to pay annual rentals for Liberty Star’s federal lode mining claims for the Tombstone project in the State of Arizona. The rental period begins at noon on September 1st through the following September 1st and rental payments are due by the first day of the rental period. The annual rentals are $200 per claim. The rentals due by September 1, 2024 for the period from September 1, 2024 through September 1, 2025 of $15,345 have been paid.   We are required to pay annual rentals for our Arizona State Land Department Mineral Exploration Permits (“AZ MEP”) at our Tombstone Hay Mountain project in the State of Arizona. AZ MEP permits cost $500 per permit per year in non-refundable filing fees and are valid for 1 year and renewable for up to 5 years. The rental fee is $2.00 per acre for the first year, which includes the second year, and $1.00 per acre per year for years three through five. The minimum work expenditure requirements are $10 per acre per year for years one and two and $20 per acre per year for years three through five. If the minimum work expenditure requirement is not met the applicant can pay an equal amount in fees to the Arizona State Land Department to keep the AZ MEP permits current. The rental period begins on the date of acceptance for each permit. Rental payments are due by the first day of the rental period. We hold AZ MEP permits for 12,878.18 acres at our Tombstone project. We paid filing and rental fees for our AZ MEPs before their respective due dates in the amount of $27,264.

v3.24.4

Subsequent Events	9 Months Ended
	Oct. 31, 2024
Subsequent Events [Abstract]
Subsequent Events	NOTE 9 – Subsequent Events   The Company has evaluated subsequent events through the filing date of this Form 10-Q and determined that the following subsequent events have occurred that would require recognition in the consolidated financial statements or disclosures in the notes thereto.   On November 8, 2024, the Investor purchased 258,228 restricted shares of the Company’s common stock for net proceeds of $26,461 ($0.10 per share), after deducting the legal fees and clearing expenses.   On November 22, 2024, the Investor purchased 318,322 restricted shares of the Company’s common stock for net proceeds of $26,884 ($0.09 per share), after deducting the legal fees and clearing expenses.   On December 2, 2024, the Company entered into a promissory note with 1800 Diagonal Lending in the aggregate principal amount of $67,200 (the “December 2024 Note”). The note bears interest at 10%, with an Original Issue Discount of $11,200 plus an additional $6,000 to pay for transaction fees of the lender, matures on September 15, 2025. Pursuant to the terms of the Note, the outstanding principal and accrued interest on the Note shall be paid in 4 set monthly cash payments beginning six months from the effective date. The note may be prepaid with no penalty. The note allows an event of default which may be convertible into shares of the Company’s common stock as set forth therein. At any time following an event of default, the note is convertible into shares of the Company’s common stock at a price of 65% of the lowest weighted average market price of the Company’s common stock during the 10 trading days prior to conversion.   On December 11, 2024, the Investor purchased 213,135 restricted shares of the Company’s common stock for net proceeds of $12,675 ($0.067 per share), after deducting the legal fees and clearing expenses.

v3.24.4

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Oct. 31, 2024
Accounting Policies [Abstract]
Fair Value	Fair Value   Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) ASC 820 Fair Value Measurements and Disclosures (“ASC 820”), defines fair value, establishes a framework for measuring fair value and enhances disclosures about fair value measurements. It defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value:   Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities.   Level 2: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities that are not active; and model-driven valuations whose inputs are observable or whose significant value drivers are observable. Valuations may be obtained from, or corroborated by, third-party pricing services.   Level 3: Unobservable inputs to measure fair value of assets and liabilities for which there is little, if any market activity at the measurement date, using reasonable inputs and assumptions based upon the best information at the time, to the extent that inputs are available without undue cost and effort.    Schedule of Fair Value of Financial Instruments               Fair value measurements at reporting date using:   Description     Fair Value       Quoted prices in active markets for identical liabilities (Level 1)       Significant other observable inputs (Level 2)       Significant unobservable inputs (Level 3)   Warrant and convertible note derivative liabilities at October 31, 2024   $ 637,477       –       –     $ 637,477   Warrant and convertible note derivative liabilities at January 31, 2024   $ 2,547,458       –       –     $ 2,547,458     Our financial instruments consist of cash and cash equivalents, prepaid expenses, accounts payable, accrued liabilities, notes payable, convertible notes payable, and derivative liabilities. It is management’s opinion that we are not exposed to significant interest, currency or credit risks arising from these financial instruments. With the exception of the derivative liabilities, the fair value of these financial instruments approximates their carrying values based on their short maturities or for long-term debt based on borrowing rates currently available to us for loans with similar terms and maturities. Gains and losses recognized on changes in estimated fair value of the derivative liabilities are reported in other income (expense) as gain (loss) on change in fair value of derivative liabilities.
Net income (loss) per share	Net income (loss) per share   Basic net income (loss) per common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding during the period. Potential common stock equivalents are determined using the treasury stock method. For diluted net income (loss) per share purposes, the Company excludes stock options and other stock-based awards, including shares issued as a result of option exercises that are subject to repurchase by the Company, whose effect would be anti-dilutive from the calculation.   During the three and nine months ended October 31, 2024, the impact of 1,525,386 and 1,743,667 of stock options and 9,281,827 and 10,412,006 of warrants and 0 shares issuable from convertible notes, respectively, were considered for their dilutive effects. During the three and nine months ended October 31, 2023, the impact of 0 of stock options, 2,099,941 and 3,450,319 of warrants, respectively, were excluded from the calculation as their impact would be anti-dilutive.   A reconciliation of the weighted average shares outstanding used in basic and diluted earnings per share computation is as follows:  Schedule of Reconciliation of Weighted Average Shares Outstanding     2024     2023     2024     2023       For the Three Months Ended     For the Nine Months Ended       October 31,     October 31,       2024     2023     2024     2023   Basic income (loss) per common share                                 Net income (loss) available to common shareholders   $ 926,992     $ (252,609 )   $ 2,387,518     $ (574,567 ) Derivative (gain) loss associated with convertible debt     (11,432 )     -       (14,876 )     -   Interest expense associated with convertible debt     (5,142 )     -       (16,415 )     -   Net income (loss) for dilutive calculation   $ 910,418     $ (252,609 )   $ 2,356,227     $ (574,567 )                                   Weighted average common shares outstanding     50,794,090       32,289,211       50,193,594       24,676,301   Dilutive effect of convertible debt     -       -       -       -   Dilutive effect of common stock warrants     9,281,827       -       10,412,006       -   Dilutive effect of common stock options     1,525,386       -       1,743,667       -   Weighted average shares outstanding for diluted net income (loss) per share     61,601,303       32,289,211       62,349,267       24,676,301

v3.24.4

Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Oct. 31, 2024
Accounting Policies [Abstract]
Schedule of Fair Value of Financial Instruments	Schedule of Fair Value of Financial Instruments               Fair value measurements at reporting date using:   Description     Fair Value       Quoted prices in active markets for identical liabilities (Level 1)       Significant other observable inputs (Level 2)       Significant unobservable inputs (Level 3)   Warrant and convertible note derivative liabilities at October 31, 2024   $ 637,477       –       –     $ 637,477   Warrant and convertible note derivative liabilities at January 31, 2024   $ 2,547,458       –       –     $ 2,547,458
Schedule of Reconciliation of Weighted Average Shares Outstanding	A reconciliation of the weighted average shares outstanding used in basic and diluted earnings per share computation is as follows:  Schedule of Reconciliation of Weighted Average Shares Outstanding     2024     2023     2024     2023       For the Three Months Ended     For the Nine Months Ended       October 31,     October 31,       2024     2023     2024     2023   Basic income (loss) per common share                                 Net income (loss) available to common shareholders   $ 926,992     $ (252,609 )   $ 2,387,518     $ (574,567 ) Derivative (gain) loss associated with convertible debt     (11,432 )     -       (14,876 )     -   Interest expense associated with convertible debt     (5,142 )     -       (16,415 )     -   Net income (loss) for dilutive calculation   $ 910,418     $ (252,609 )   $ 2,356,227     $ (574,567 )                                   Weighted average common shares outstanding     50,794,090       32,289,211       50,193,594       24,676,301   Dilutive effect of convertible debt     -       -       -       -   Dilutive effect of common stock warrants     9,281,827       -       10,412,006       -   Dilutive effect of common stock options     1,525,386       -       1,743,667       -   Weighted average shares outstanding for diluted net income (loss) per share     61,601,303       32,289,211       62,349,267       24,676,301

v3.24.4

Stockholders’ deficit (Tables)	9 Months Ended
	Oct. 31, 2024
Share-Based Payment Arrangement [Abstract]
Schedule of Stock Option Activity	Qualified and non-qualified incentive stock options outstanding at October 31, 2024 are as follows:  Schedule of Stock Option Activity     Number of options     Weighted average exercise price per share   Outstanding, January 31, 2024     2,808,760     $ 0.83   Granted     632,238       0.22   Expired     –       –   Exercised     (75,000 )     0.05   Outstanding, October 31, 2024     3,365,998     $ 0.74                     Exercisable, October 31, 2024     3,203,498     $ 0.76
Schedule of Stock Warrants Outstanding	Stock warrants outstanding at October 31, 2024 are as follows:  Schedule of Stock Warrants Outstanding     Number of warrants     Weighted average exercise price per share   Outstanding, January 31, 2024     14,254,813     $ 0.21   Issued     –       –   Expired     (222,740 )     1.26   Exercised     –       –   Outstanding, October 31, 2024     14,032,073     $ 0.19                     Exercisable, October 31, 2024     13,524,541     $ 0.12

v3.24.4

Derivative Liabilities (Tables)	9 Months Ended
	Oct. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Changes in Fair value of Derivative Liabilities	The following table sets forth a reconciliation of changes in the fair value of the Company’s derivative liabilities:  Schedule of Changes in Fair value of Derivative Liabilities     Nine months ended October 31,       2024     2023   Beginning balance   $ 2,547,458     $ 172,393   Total gain     (3,783,056 )     (160,551 ) Settlements     (52,476 )     (156,309 ) Additions recognized as debt discount     67,352       146,368   Changes due to tainted (untainted) warrants     1,858,199       (1,901 ) Ending balance   $ 637,477     $ -                     Change in fair value of derivative liabilities included in earnings relating to derivatives   $ (3,783,056 )   $ (160,551 )

v3.24.4

Long-term debt and convertible promissory notes (Tables)	9 Months Ended
	Oct. 31, 2024
Debt Disclosure [Abstract]
Schedule of Convertible Promissory Notes	Following is a summary of convertible promissory notes:  Schedule of Convertible Promissory Notes     October 31, 2024     January 31, 2024                 8% convertible note payable issued January 2024, due October 2024   $ -     $ 110,000   10% convertible note payable issued February 2024, due November 2024     10,500       –   10% convertible note payable issued June 2024, due March 2025     66,000       –   10% convertible note payable issued August 2024, due May 2025     67,200       –   10% convertible note payable issued October 2024, due July 2025     97,200       –   Convertible note payable     240,900       110,000   Less debt discount     (39,917 )     (15,000 ) Less current portion of convertible notes     (200,983 )     (95,000 ) Long-term convertible notes payable   $ –     $ –

v3.24.4

Schedule of Fair Value of Financial Instruments (Details) - USD ($)	Oct. 31, 2024	Jan. 31, 2024
Platform Operator, Crypto Asset [Line Items]
Warrant and convertible note derivative liabilities	$ 637,477	$ 2,547,458
Fair Value, Inputs, Level 1 [Member]
Platform Operator, Crypto Asset [Line Items]
Warrant and convertible note derivative liabilities
Fair Value, Inputs, Level 2 [Member]
Platform Operator, Crypto Asset [Line Items]
Warrant and convertible note derivative liabilities
Fair Value, Inputs, Level 3 [Member]
Platform Operator, Crypto Asset [Line Items]
Warrant and convertible note derivative liabilities	$ 637,477	$ 2,547,458

v3.24.4

Schedule of Reconciliation of Weighted Average Shares Outstanding (Details) - USD ($)	3 Months Ended						9 Months Ended
	Oct. 31, 2024	Jul. 31, 2024	Apr. 30, 2024	Oct. 31, 2023	Jul. 31, 2023	Apr. 30, 2023	Oct. 31, 2024	Oct. 31, 2023
Accounting Policies [Abstract]
Net income ( loss)	$ 926,992	$ 1,149,145	$ 311,381	$ (252,609)	$ (203,379)	$ (118,579)	$ 2,387,518	$ (574,567)
Derivative (gain) loss associated with convertible debt	(11,432)						(14,876)
Interest expense associated with convertible debt	(5,142)						(16,415)
Net income (loss) for dilutive calculation	$ 910,418			$ (252,609)			$ 2,356,227	$ (574,567)
Weighted average common shares outstanding	50,794,090			32,289,211			50,193,594	24,676,301
Dilutive effect of convertible debt
Dilutive effect of common stock warrants	9,281,827						10,412,006
Dilutive effect of common stock options	1,525,386						1,743,667
Weighted average shares outstanding for diluted net income (loss) per share	61,601,303			32,289,211			62,349,267	24,676,301

v3.24.4

Summary of Significant Accounting Policies (Details Narrative) - shares	3 Months Ended		9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Dilutive effects impact of stock options	1,525,386		1,743,667
Dilutive effects impact of warrants	9,281,827		10,412,006
Dilutive effect of convertible debt
Share-Based Payment Arrangement, Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Dilutive effects impact of warrants		0		0
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Dilutive effects impact of warrants		2,099,941		3,450,319

v3.24.4

Related Party Transactions (Details Narrative) - USD ($)											9 Months Ended		12 Months Ended
	Aug. 23, 2024	Jul. 05, 2024	Jun. 28, 2024	May 20, 2024	May 01, 2024	Apr. 03, 2024	Feb. 21, 2024	Feb. 13, 2024	Jan. 25, 2024	Mar. 13, 2023	Oct. 31, 2024	Oct. 31, 2023	Jan. 31, 2024	Feb. 12, 2024	Jan. 31, 2023
Related Party Transaction [Line Items]
Advances from chairman											$ 467,000	$ 35,000
Related party debt paid											$ 25,000
Stock options exercised							75,000
Shares issued during option exercise							70,002				75,000
Number of options, granted											632,238
Weighted average exercise price per share, granted											$ 0.22
Fair value stock price	$ 0.226		$ 0.226								$ 0.178
Exercise price	$ 0.226		$ 0.226
Term	6 years 3 months 18 days		10 years
Volatility	191.00%		178.00%
Discount rate, minimum	3.71%		4.36%
Dividend yield	0.00%		0.00%
Chairman [Member]
Related Party Transaction [Line Items]
Advances from chairman											$ 210,000
Related party debt paid											25,000
Board of Directors [Member]
Related Party Transaction [Line Items]
Number of options, granted			337,501
Options expiration period			10 years
Weighted average exercise price per share, granted			$ 0.226
Total fair value of options vested upon issuance			$ 76,275
Patricia Madaris [Member]
Related Party Transaction [Line Items]
Accrued unpaid vacation											8,117		$ 0
Related Party [Member]
Related Party Transaction [Line Items]
Advance related party balance											185,000
Promissory note, face value		$ 70,000		$ 67,000	$ 45,000	$ 75,000		$ 210,000
Interest rate		10.00%		10.00%	10.00%	10.00%		10.00%
Maturity date		Jul. 05, 2025		May 20, 2025	May 01, 2025	Apr. 03, 2025		Feb. 13, 2025
Notes payable to related party											736,598		326,828
Brett Gross [Member]
Related Party Transaction [Line Items]
Related party debt paid											40,000
Promissory note, face value															$ 50,000
Increase in promissory note													$ 86,579
Interest rate													10.00%
Maturity date													Jan. 31, 2024
Recourse loan														$ 16,750
Accrued interest														$ 480
Notes payable to related party											$ 19,598		$ 76,828
Number of options, granted										250,000
Options expiration period										10 years
Director [Member]
Related Party Transaction [Line Items]
Promissory note, face value									$ 250,000
Interest rate									10.00%
Maturity date									Jan. 25, 2025

v3.24.4

Schedule of Stock Option Activity (Details) - $ / shares		9 Months Ended
	Feb. 21, 2024	Oct. 31, 2024
Share-Based Payment Arrangement [Abstract]
Number of options, outstanding beginning		2,808,760
Weighted average exercise price per share, outstanding beginning		$ 0.83
Number of options, granted		632,238
Weighted average exercise price per share, granted		$ 0.22
Number of options, expired
Weighted average exercise price per share, expired
Number of options, exercised	(70,002)	(75,000)
Weighted average exercise price, Exercised		$ 0.05
Number of options, outstanding ending		3,365,998
Weighted average exercise price per share, outstanding ending		$ 0.74
Number of options, exercisable		3,203,498
Weighted average exercise price per share, exercisable		$ 0.76

v3.24.4

Schedule of Stock Warrants Outstanding (Details) - Warrant [Member]	9 Months Ended
	Oct. 31, 2024 $ / shares shares
Number of warrants, Outstanding | shares	14,254,813
Weighted average exercise price per share, Outstanding | $ / shares	$ 0.21
Number of warrants, Issued | shares
Weighted average exercise price per share, Issued | $ / shares
Number of warrants, Expired | shares	(222,740)
Weighted average exercise price per share, Expired | $ / shares	$ 1.26
Number of warrants, Exercised | shares
Weighted average exercise price per share, Exercised | $ / shares
Number of warrants, Outstanding | shares	14,032,073
Weighted average exercise price per share, Outstanding | $ / shares	$ 0.19
Number of warrants, Exercisable | shares	13,524,541
Weighted average exercise price per share, Exercisable | $ / shares	$ 0.12

v3.24.4

Stockholders’ deficit (Details Narrative) - USD ($)												3 Months Ended						9 Months Ended		12 Months Ended
	Oct. 24, 2024	Sep. 25, 2024	Aug. 23, 2024	Aug. 05, 2024	Jun. 28, 2024	Feb. 21, 2024	Feb. 12, 2024	Dec. 04, 2023	May 26, 2023	Mar. 13, 2023	Sep. 29, 2022	Oct. 31, 2024	Jul. 31, 2024	Apr. 30, 2024	Oct. 31, 2023	Jul. 31, 2023	Apr. 30, 2023	Oct. 31, 2024	Oct. 31, 2023	Jan. 31, 2024	Jul. 03, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Common stock shares authorized												149,500,000						149,500,000		149,500,000	75,000,000
Issuance of stock, value												$ 6,414
Net proceeds of common stock																		$ 6,414
Number of options, granted																		632,238
Exercise price												$ 0.74						$ 0.74		$ 0.83
Option exercised, value
Option exercised, shares						70,002												75,000
Subscription receivable														16,750
Subscription receivable												$ 101,100						$ 101,100		$ 117,850
Options, weighted average remaining life																		9 years 1 month 9 days
Options, aggregate intrinsic value												$ 253,984						$ 253,984
Fair value stock price			$ 0.226		$ 0.226							$ 0.178						$ 0.178
Weighted average exercise price per share, granted																		$ 0.22
Stock options, compensation expense																		$ 357,330	63,243
Fair value exercise price			$ 0.226		$ 0.226
Fair value term			6 years 3 months 18 days		10 years
Fair value volatility			191.00%		178.00%
Fair value discount rate			3.71%		4.36%
Fair value dividend yield			0.00%		0.00%
Unrecognized share-based compensation												$ 47,901						$ 47,901
Purchase warrants outstanding												14,032,073						14,032,073
Purchase warrants exercisable												13,524,541						13,524,541
Warrants weighted average remaining life												1 year 9 months						1 year 9 months
Weighted average exercise price of warrant												$ 0.12						$ 0.12
Aggregate intrinsic value												$ 1,618,975						$ 1,618,975
Brett Gross [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of options, granted										250,000
Options expiration period										10 years
Exercise price										$ 0.067
Fair value of option granted										$ 16,750
Interest rate																				10.00%
Maturity date																				Jan. 31, 2024
Subscription receivable							$ 16,750
Accrued interest							$ 480
Officers Employees and Consultants [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock options, compensation expense																		300,101	$ 38,553
Common Stock [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Issuance of stock												79,976
Issuance of stock, value												$ 1
Net proceeds of common stock																		$ 500,000
Shares of common stock for conversions												682,008	185,381		2,725,574	1,690,073	1,251,270	867,389
Shares of common stock for conversions, value																		$ 110,000
Interest on convertible notes payable																		$ 4,000
Option exercised, value														$ 1			$ 3
Option exercised, shares														70,002			250,000
Subscription receivable
Common Stock [Member] | Maximum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Common stock conversion price												$ 0.1888						$ 0.1888
Common Stock [Member] | Minimum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Common stock conversion price												$ 0.0961						$ 0.0961
Other Additional Capital [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Deferred offering cost												$ 1,000						$ 1,000
Investment Agreement [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Unamortized deferred offering cost												$ 20,000						$ 20,000
Investment Agreement [Member] | Investor [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Issuance of stock	100,000
Issuance of stock, value	$ 20,000
Sale of stock description		The amount that we shall be entitled to sell to Investor shall be equal to two hundred percent (200%) of the average daily volume (U.S. market only) of the common stock for the ten (10) trading days prior to the applicable notice date so long as such amount does not exceed a calculated dollar amount per every 10 days of $500,000. The minimum amount shall be equal to $10,000.
Investment Agreement [Member] | Investor [Member] | Maximum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of shares purchased		10,000,000
Note Agreements [Member] | Brett Gross [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Option exercised, value										$ 16,750
Option exercised, shares										250,000
Interest rate										3.15%
Maturity date										Mar. 15, 2028
Investor [Member] | Stock Compensation And Subscription Agreement [Member] | Common Stock [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share based compensation				$ 45,000					$ 12,229
Employees [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of options, granted											674,000
Options expiration period											10 years
Exercise price											$ 0.15
Fair value of option granted											$ 104,226
Employees [Member] | Note Agreements [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Option exercised, value											$ 101,100
Option exercised, shares											674,000
Interest rate											3.15%
Maturity date											Sep. 30, 2027
Geologist [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Options expiration period								3 years
Compensation per month								$ 4,000
Options granted								10,000										54,000
Stock options grants per month								4,000
Fair value of options granted																		$ 15,024
Stock options, compensation expense																		$ 15,024
Geologist [Member] | Maximum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Weighted average exercise price per share, granted																		$ 0.725
Geologist [Member] | Minimum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Weighted average exercise price per share, granted																		$ 0.047
Employee [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of options, granted					165,737
Options expiration period					10 years
Weighted average exercise price per share, granted					$ 0.226
Total fair value of options vested upon issuance					$ 37,457
Board [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of options, granted			75,000
Options expiration period			10 years
Weighted average exercise price per share, granted			$ 0.16
Total fair value of options vested upon issuance			$ 12,337
Restricted Stock [Member] | Investment Agreement [Member] | Investor [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of shares purchased																		79,976
Net proceeds of common stock																		$ 6,414
Share price per share												$ 0.08						$ 0.08
Restricted Stock [Member] | Investor [Member] | Stock Compensation And Subscription Agreement [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Issuance of stock				225,000					978,300
Issuance of stock, value				$ 45,000

v3.24.4

Schedule of Changes in Fair value of Derivative Liabilities (Details) - USD ($)	3 Months Ended		9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Beginning balance			$ 2,547,458	$ 172,393
Total gains			(3,783,056)	(160,551)
Settlements			(52,476)	(156,309)
Additions recognized as debt discount			67,352	146,368
Additions due to tainted warrants			1,858,199	(1,901)
Ending balance	$ 637,477		637,477
Change in fair value of derivative liabilities included in earnings relating to derivatives	$ (1,289,458)	$ (86,112)	$ (3,783,056)	$ (160,551)

v3.24.4

Derivative Liabilities (Details Narrative)	3 Months Ended		9 Months Ended
	Oct. 31, 2024 USD ($) $ / shares shares	Oct. 31, 2023 USD ($)	Oct. 31, 2024 USD ($) $ / shares shares	Oct. 31, 2023 USD ($)	Jan. 31, 2024 shares	Oct. 31, 2021 shares
Derivative [Line Items]
Common stock, shares outstanding | shares	51,156,228		51,156,228		49,813,861	10,888,894
Common stock, shares issued | shares	51,156,228		51,156,228		49,813,861
Common stock shares growth monthly percentage	2.49%		2.49%
Proceeds from sale of common stock			$ 6,414
Amortization of debt discount			112,835	197,477
Gain on derivative liabilities	$ 1,289,458	$ 86,112	3,783,056	160,551
Reclassification due to conversion of convertible notes				156,309
Derivative Liability [Member]
Derivative [Line Items]
Derivative loss			0	0
Amortization of debt discount			67,352	146,368
Interest expense			67,352	197,477
Unamortized debt discount	0	0	0	0
Derivative Liability [Member] | Convertible Debt [Member]
Derivative [Line Items]
Derivative liabilities	$ 67,352	$ 146,368	67,352	$ 146,368
Common Stock [Member]
Derivative [Line Items]
Proceeds from sale of common stock			$ 500,000
Common stock, discount percentage	25.00%		25.00%
Measurement Input, Price Volatility [Member]
Derivative [Line Items]
Derivative liabilities, measurement input	188.8		188.8
Measurement Input, Expected Term [Member]
Derivative [Line Items]
Expected term	1 year 9 months 18 days		1 year 9 months 18 days
Measurement Input, Risk Free Interest Rate [Member]
Derivative [Line Items]
Derivative liabilities, measurement input	4.36		4.36
Measurement Input, Expected Dividend Rate [Member]
Derivative [Line Items]
Derivative liabilities, measurement input	0		0
Measurement Input, Exercise Price [Member]
Derivative [Line Items]
Derivative liabilities, measurement input | $ / shares	20		20
Measurement Input, Exercise Price [Member] | Share-Based Payment Arrangement, Option [Member]
Derivative [Line Items]
Derivative liabilities, measurement input | $ / shares	1		1
Measurement Input, Exercise Price [Member] | Minimum [Member]
Derivative [Line Items]
Derivative liability exercise price | $ / shares	$ 0.04		$ 0.04
Measurement Input, Exercise Price [Member] | Maximum [Member]
Derivative [Line Items]
Derivative liability exercise price | $ / shares	$ 16.20		$ 16.20

v3.24.4

Schedule of Convertible Promissory Notes (Details) - USD ($)	Oct. 31, 2024	Jan. 31, 2024
Short-Term Debt [Line Items]
Convertible note payable	$ 240,900	$ 110,000
Less debt discount	(39,917)	(15,000)
Less current portion of convertible notes	(200,983)	(95,000)
Long-term convertible notes payable
January 2024 Note [Member]
Short-Term Debt [Line Items]
Convertible note payable		110,000
February 2024 Note [Member]
Short-Term Debt [Line Items]
Convertible note payable	10,500
June 2024 Note [Member]
Short-Term Debt [Line Items]
Convertible note payable	66,000
August 2024 Note [Member]
Short-Term Debt [Line Items]
Convertible note payable	67,200
October 2024 Note [Member]
Short-Term Debt [Line Items]
Convertible note payable	$ 97,200

v3.24.4

Summary of Convertible Promissory Notes (Details) (Parenthetical)	9 Months Ended
	Oct. 31, 2024
January 2024 Note [Member]
Short-Term Debt [Line Items]
Notes issuance date	2024-01
Notes maturity period	2024-10
February 2024 Note [Member]
Short-Term Debt [Line Items]
Notes issuance date	2024-02
Notes maturity period	2024-11
June 2024 Note [Member]
Short-Term Debt [Line Items]
Notes issuance date	2024-06
Notes maturity period	2025-03
August 2024 Note [Member]
Short-Term Debt [Line Items]
Notes issuance date	2024-08
Notes maturity period	2025-05
October 2024 Note [Member]
Short-Term Debt [Line Items]
Notes issuance date	2024-10
Notes maturity period	2025-07

v3.24.4

Long-term debt and convertible promissory notes (Details Narrative)							1 Months Ended	9 Months Ended		12 Months Ended
	Oct. 22, 2024 USD ($) Integer	Aug. 28, 2024 USD ($) Integer	Jun. 13, 2024 USD ($) Integer	Feb. 23, 2024 USD ($) Integer	Jan. 12, 2024 USD ($) Integer	Jun. 22, 2020 USD ($)	Apr. 30, 2024 USD ($)	Oct. 31, 2024 USD ($) shares	Oct. 31, 2023 USD ($)	Jan. 31, 2024 USD ($)
Short-Term Debt [Line Items]
Debt discount								$ 67,352	$ 146,368
Original issue debt discounts and fees paid								70,400	17,350
Amortization of debt discount								112,835	$ 197,477
Note principal balance								40,922		$ 32,400
Long term payable								32,400		32,400
Current portion of notes payable								8,522
Accured interest								2,729		2,729
SBA's Economic Injury Disaster Loan Program [Member]
Short-Term Debt [Line Items]
Fee amount						$ 100
Proceeds from loans originations						$ 32,300
Line of credit facility interest rate during period						3.75%
Debt instrument term						30 years
Debt instrument periodic payment						$ 158
Premium Finance Agreement [Member]
Short-Term Debt [Line Items]
Interest rate, percentage							13.20%
Debt instrument periodic payment							$ 2,903
Insurance policy premiums							$ 33,500
Insurance policy premiums description							one-year policy period
Insurance financed							$ 24,750
January 2024 Note [Member]
Short-Term Debt [Line Items]
Debt instrument, face value					$ 110,000
Interest rate, percentage					8.00%
Original issue discount					$ 10,000					15,000
Fee amount					$ 5,000
Debt instrument, maturity date					Mar. 24, 2024
Debt instrument convertible consecutive trading days | Integer					180
Common stock conversion, percentage					75.00%
Debt instrument, convertible, threshold trading days | Integer					10
Debt instrument conversion, amount								$ 110,000
Debt conversion on convertible shares | shares								867,389
Note balance								$ 0		$ 95,000
February 2024 Note [Member]
Short-Term Debt [Line Items]
Debt instrument, face value				$ 126,000
Interest rate, percentage				10.00%
Original issue discount				$ 21,000				2,776
Fee amount				$ 5,000
Debt instrument, maturity date				Nov. 30, 2024
Common stock conversion, percentage				65.00%
Debt instrument, convertible, threshold trading days | Integer				10
Note balance								7,724
Repayment of notes								115,500
June 2024 Note [Member]
Short-Term Debt [Line Items]
Debt instrument, face value			$ 126,000
Interest rate, percentage			10.00%
Original issue discount			$ 21,000					2,455
Fee amount			$ 5,000
Debt instrument, maturity date			Mar. 15, 2025
Common stock conversion, percentage			65.00%
Debt instrument, convertible, threshold trading days | Integer			10
Note balance								63,545
August 2024 Note [Member]
Short-Term Debt [Line Items]
Debt instrument, face value		$ 67,200
Interest rate, percentage		10.00%
Original issue discount		$ 11,200						13,197
Fee amount		$ 6,000
Debt instrument, maturity date		May 30, 2025
Common stock conversion, percentage		65.00%
Debt instrument, convertible, threshold trading days | Integer		10
Note balance								54,003
October 2024 Note [Member]
Short-Term Debt [Line Items]
Debt instrument, face value	$ 97,200
Interest rate, percentage	10.00%
Original issue discount	$ 16,200							21,489
Fee amount	$ 6,000
Debt instrument, maturity date	Jul. 30, 2025
Common stock conversion, percentage	65.00%
Debt instrument, convertible, threshold trading days | Integer	10
Note balance								$ 75,711

v3.24.4

Commitments and contingencies (Details Narrative)	9 Months Ended
	Oct. 31, 2024 USD ($) a $ / shares	Oct. 31, 2025 USD ($)
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Payments for rent	$ 200
Lease due date	Sep. 01, 2024
AZMEP [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Project validity description	AZ MEP permits cost $500 per permit per year in non-refundable filing fees and are valid for 1 year and renewable for up to 5 years.
AZMEP [Member] | Phase One [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Minimum work expenditure requirements	$ 27,264
AZMEP [Member] | First Year [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Rental fee per acre | $ / shares	$ 2.00
AZMEP [Member] | Three Through Five Year [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Rental fee per acre | $ / shares	$ 1.00
Minimum work expenditure requirements	$ 20
AZMEP [Member] | One and Two Years [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Minimum work expenditure requirements	$ 10
Tombstone Project [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Project validity description	The rentals due by September 1, 2024 for the period from September 1, 2024 through September 1, 2025 of $15,345 have been paid.
Area of land | a	12,878.18
Tombstone Project [Member] | Forecast [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Accrued rent		$ 15,345
Tombstone Region of Arizona [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Payments for rent	$ 105

v3.24.4

Subsequent Events (Details Narrative) - USD ($)					9 Months Ended
	Dec. 11, 2024	Dec. 02, 2024	Nov. 22, 2024	Nov. 08, 2024	Oct. 31, 2024	Oct. 31, 2023	Aug. 23, 2024	Jun. 28, 2024
Subsequent Event [Line Items]
Proceeds from the issuance of common stock for cash, net					$ 6,414
Share price per share					$ 0.178		$ 0.226	$ 0.226
Subsequent Event [Member]
Subsequent Event [Line Items]
Aggregate principal amount		$ 67,200
Note bears interest percent		10.00%
Original issue discount		$ 11,200
Pay for transaction fees of lender		$ 6,000
Debt maturity date		Sep. 15, 2025
Note convertible into shares description		the note is convertible into shares of the Company’s common stock at a price of 65% of the lowest weighted average market price of the Company’s common stock during the 10 trading days prior to conversion.
Subsequent Event [Member] | Restricted Stock [Member] | Investor [Member]
Subsequent Event [Line Items]
Shares issued	213,135		318,322	258,228
Proceeds from the issuance of common stock for cash, net	$ 12,675		$ 26,884	$ 26,461
Share price per share	$ 0.067		$ 0.09	$ 0.10

---